{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:48:51Z","timestamp":1793972931195,"version":"4.8.0"},"reference-count":345,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003768","name":"Universit\u00e9 de Strasbourg","doi-asserted-by":"publisher","award":["Idex PhD program"],"award-info":[{"award-number":["Idex PhD program"]}],"id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003768","name":"Universit\u00e9 de Strasbourg","doi-asserted-by":"publisher","award":["ITI Neurostra program"],"award-info":[{"award-number":["ITI Neurostra program"]}],"id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003768","name":"Universit\u00e9 de Strasbourg","doi-asserted-by":"publisher","award":["ITI Neurostra program"],"award-info":[{"award-number":["ITI Neurostra program"]}],"id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by progressive decline of cognitive functions, yet its underlying aetiology remains elusive. While amyloid-\u03b2 (A\u03b2) and tau pathologies have been extensively studied, emerging evidence suggests that metal and especially copper dyshomeostasis may also play a crucial role in the pathogenesis of AD. This review explores the intricate relationship between copper and AD, shedding light on the multifaceted mechanisms through which copper dysregulation contributes to neurodegeneration. We delve into the impact of copper ions on A\u03b2 aggregation, tau phosphorylation, and oxidative stress, providing a comprehensive overview of the molecular pathways involved. Furthermore, we discuss the interplay between different brain cell types and the impact Cu dysregulation may have on them. The therapeutic implications of targeting copper dysregulation for AD treatment are also addressed, emphasizing the potential of copper-modulating agents in ameliorating cognitive decline. In summary, this review discusses copper dyshomeostasis as a central player in the intricate tapestry of AD pathology, offering new insights and avenues for therapeutic interventions.<\/jats:p>","DOI":"10.1186\/s40035-025-00504-6","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T06:48:25Z","timestamp":1755845305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cell-specific copper dyshomeostasis mechanism in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Michael","family":"Okafor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Faller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4752-4907","authenticated-orcid":false,"given":"Nicolas","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"504_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ca.980080612","volume":"8","author":"RA Stelzmann","year":"1995","unstructured":"Stelzmann RA, Norman Schnitzlein H, Reed Murtagh F. An english translation of alzheimer\u2019s 1907 paper, \u201c\u00fcber eine eigenartige erkankung der hirnrinde.\u201d Clin Anat. 1995;8:429\u201331.","journal-title":"Clin Anat"},{"key":"504_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s004060050027","volume":"248","author":"H-J M\u00f6ller","year":"1998","unstructured":"M\u00f6ller H-J, Graeber MB. The case described by Alois Alzheimer in 1911. Eur Arch Psychiatry Clin Neurosci. 1998;248:111\u201322.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"504_CR3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/00005053-191207000-00002","volume":"39","author":"SC Fuller","year":"1912","unstructured":"Fuller SC. Alzheimer\u2019s disease (senium pr\u00e6cox): the report of a case and review of published cases. J Nerv Ment Dis. 1912;39:440.","journal-title":"J Nerv Ment Dis"},{"key":"504_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0197-4580(92)90027-U","volume":"13","author":"DW Dickson","year":"1992","unstructured":"Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging. 1992;13:179\u201389.","journal-title":"Neurobiol Aging"},{"key":"504_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/YCO.0000000000000239","volume":"29","author":"S Saito","year":"2016","unstructured":"Saito S, Ihara M. Interaction between cerebrovascular disease and Alzheimer pathology. Curr Opin Psychiatry. 2016;29:168.","journal-title":"Curr Opin Psychiatry"},{"key":"504_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.643357","author":"S Saito","year":"2021","unstructured":"Saito S, Tanaka M, Satoh-Asahara N, Carare RO, Ihara M. Taxifolin: a potential therapeutic agent for cerebral amyloid angiopathy. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.643357.","journal-title":"Front Pharmacol"},{"key":"504_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/WNL.0000000000008924","volume":"94","author":"R Waziry","year":"2020","unstructured":"Waziry R, Chibnik LB, Bos D, Ikram MK, Hofman A. Risk of hemorrhagic and ischemic stroke in patients with Alzheimer disease. Neurology. 2020;94:265\u201372.","journal-title":"Neurology"},{"key":"504_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak H, Braak E. Staging of alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol Aging. 1995;16:271\u20138.","journal-title":"Neurobiol Aging"},{"key":"504_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl). 1991;82:239\u201359.","journal-title":"Acta Neuropathol (Berl)"},{"key":"504_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40478-022-01394-9","volume":"10","author":"G Paterno","year":"2022","unstructured":"Paterno G, Bell BM, Gorion K-MM, Prokop S, Giasson BI. Reassessment of neuronal tau distribution in adult human brain and implications for tau pathobiology. Acta Neuropathol Commun. 2022;10:94.","journal-title":"Acta Neuropathol Commun"},{"key":"504_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.neurobiolaging.2006.02.001","volume":"28","author":"S-K Herukka","year":"2007","unstructured":"Herukka S-K, Helisalmi S, Hallikainen M, Tervo S, Soininen H, Pirttil\u00e4 T. CSF Abeta42, Tau and phosphorylated Tau, APOE epsilon4 allele and MCI type in progressive MCI. Neurobiol Aging. 2007;28:507\u201314.","journal-title":"Neurobiol Aging"},{"key":"504_CR12","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1073\/pnas.88.6.2288","volume":"88","author":"RA Crowther","year":"1991","unstructured":"Crowther RA. Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc Natl Acad Sci. 1991;88:2288\u201392.","journal-title":"Proc Natl Acad Sci"},{"key":"504_CR13","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1515\/revneuro-2017-0006","volume":"28","author":"S Kozlov","year":"2017","unstructured":"Kozlov S, Afonin A, Evsyukov I, Bondarenko A. Alzheimer\u2019s disease: as it was in the beginning. Rev Neurosci. 2017;28:825\u201343.","journal-title":"Rev Neurosci"},{"key":"504_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/path.2885","volume":"224","author":"RJ Castellani","year":"2011","unstructured":"Castellani RJ, Smith MA. Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is \u201ctoo big to fail.\u201d J Pathol. 2011;224:147\u201352.","journal-title":"J Pathol"},{"key":"504_CR15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.tips.2016.01.005","volume":"37","author":"C Deyts","year":"2016","unstructured":"Deyts C, Thinakaran G, Parent AT. APP receptor? To be or not to be. Trends Pharmacol Sci. 2016;37:390\u2013411.","journal-title":"Trends Pharmacol Sci"},{"key":"504_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/0092-8674(95)90073-X","volume":"81","author":"H Zheng","year":"1995","unstructured":"Zheng H, Jiang M, Trumbauer ME, Sirinathsinghji DJS, Hopkins R, Smith DW, et al. \u0392-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell. 1995;81:525\u201331.","journal-title":"Cell"},{"key":"504_CR17","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1523\/JNEUROSCI.4660-04.2005","volume":"25","author":"P Wang","year":"2005","unstructured":"Wang P, Yang G, Mosier DR, Chang P, Zaidi T, Gong Y-D, et al. Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-like protein 2. J Neurosci. 2005;25:1219\u201325.","journal-title":"J Neurosci"},{"key":"504_CR18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.mod.2012.11.001","volume":"130","author":"JH Caldwell","year":"2013","unstructured":"Caldwell JH, Klevanski M, Saar M, M\u00fcller UC. Roles of the amyloid precursor protein family in the peripheral nervous system. Mech Dev. 2013;130:433\u201346.","journal-title":"Mech Dev"},{"key":"504_CR19","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1523\/JNEUROSCI.5345-07.2008","volume":"28","author":"A Schneider","year":"2008","unstructured":"Schneider A, Rajendran L, Honsho M, Gralle M, Donnert G, Wouters F, et al. Flotillin-dependent clustering of the amyloid precursor protein regulates its endocytosis and amyloidogenic processing in neurons. J Neurosci Off J Soc Neurosci. 2008;28:2874\u201382.","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"504_CR20","doi-asserted-by":"publisher","first-page":"12787","DOI":"10.1523\/JNEUROSCI.3657-09.2009","volume":"29","author":"R Vassar","year":"2009","unstructured":"Vassar R, Kovacs DM, Yan R, Wong PC. The beta-secretase enzyme BACE in health and Alzheimer\u2019s disease: regulation, cell biology, function, and therapeutic potential. J Neurosci Off J Soc Neurosci. 2009;29:12787\u201394.","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"504_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00294","author":"X Wang","year":"2017","unstructured":"Wang X, Zhou X, Li G, Zhang Y, Wu Y, Song W. Modifications and trafficking of APP in the pathogenesis of Alzheimer\u2019s disease. Front Mol Neurosci. 2017. https:\/\/doi.org\/10.3389\/fnmol.2017.00294.","journal-title":"Front Mol Neurosci"},{"key":"504_CR22","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1046\/j.1471-4159.1996.67051882.x","volume":"67","author":"K Furukawa","year":"1996","unstructured":"Furukawa K, Sopher BL, Rydel RE, Begley JG, Pham DG, Martin GM, et al. Increased activity-regulating and neuroprotective efficacy of \u03b1-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J Neurochem. 1996;67:1882\u201396.","journal-title":"J Neurochem"},{"key":"504_CR23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","volume":"89","author":"H Hampel","year":"2021","unstructured":"Hampel H, Vassar R, De Strooper B, Hardy J, Willem M, Singh N, et al. The \u03b2-secretase BACE1 in Alzheimer\u2019s disease. Biol Psychiatry. 2021;89:745\u201356.","journal-title":"Biol Psychiatry"},{"key":"504_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/B978-0-12-398270-4.00021-5","volume-title":"Neurobiol Brain Disord","author":"AV Savonenko","year":"2015","unstructured":"Savonenko AV, Melnikova T, Li T, Price DL, Wong PC. Chapter 21\u2014Alzheimer disease. In: Zigmond MJ, Rowland LP, Coyle JT, editors. Neurobiol Brain Disord. San Diego: Academic Press; 2015. p. 321\u201338."},{"key":"504_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1326-5-40","volume":"5","author":"SI Vieira","year":"2010","unstructured":"Vieira SI, Rebelo S, Esselmann H, Wiltfang J, Lah J, Lane R, et al. Retrieval of the Alzheimer\u2019s amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated. Mol Neurodegener. 2010;5:40.","journal-title":"Mol Neurodegener"},{"key":"504_CR26","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/j.1460-2075.1994.tb06360.x","volume":"13","author":"T Suzuki","year":"1994","unstructured":"Suzuki T, Oishi M, Marshak Dr, Czernik Aj, Nairn Ac, Greengard P. Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBO J. 1994;13:1114\u201322.","journal-title":"EMBO J"},{"key":"504_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1006\/bbrc.1999.0637","volume":"258","author":"T Isohara","year":"1999","unstructured":"Isohara T, Horiuchi A, Watanabe T, Ando K, Czernik AJ, Uno I, et al. Phosphorylation of the cytoplasmic domain of Alzheimer\u2019s \u03b2-amyloid precursor protein at Ser655 by a novel protein kinase. Biochem Biophys Res Commun. 1999;258:300\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"504_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF03401803","volume":"3","author":"M Oishi","year":"1997","unstructured":"Oishi M, Nairn AC, Czernik AJ, Lim GS, Isohara T, Gandy SE, et al. The cytoplasmic domain of Alzheimer\u2019s amyloid precursor protein is phosphorylated at Thr654, Ser655, and Thr668 in adult rat brain and cultured cells. Mol Med. 1997;3:111\u201323.","journal-title":"Mol Med"},{"key":"504_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000332815","volume":"10","author":"V Muresan","year":"2012","unstructured":"Muresan V, Muresan Z. A persistent stress response to impeded axonal transport leads to accumulation of amyloid-\u03b2 in the endoplasmic reticulum, and is a probable cause of sporadic Alzheimer\u2019s disease. Neurodegener Dis. 2012;10:60\u20133.","journal-title":"Neurodegener Dis"},{"key":"504_CR30","first-page":"31","volume":"17","author":"MA Hern\u00e1ndez-Sapi\u00e9ns","year":"2021","unstructured":"Hern\u00e1ndez-Sapi\u00e9ns MA, Reza-Zald\u00edvar EE, M\u00e1rquez-Aguirre AL, G\u00f3mez-Pinedo U, Matias-Guiu J, Cevallos RR, et al. Presenilin mutations and their impact on neuronal differentiation in Alzheimer\u2019s disease. Neural Regen Res. 2021;17:31\u20137.","journal-title":"Neural Regen Res"},{"key":"504_CR31","doi-asserted-by":"publisher","first-page":"12635","DOI":"10.1073\/pnas.1717180114","volume":"114","author":"H Watanabe","year":"2017","unstructured":"Watanabe H, Shen J. Dominant negative mechanism of Presenilin-1 mutations in FAD. Proc Natl Acad Sci U S A. 2017;114:12635\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"504_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1073\/pnas.0608332104","volume":"104","author":"J Shen","year":"2007","unstructured":"Shen J, Kelleher RJ. The presenilin hypothesis of Alzheimer\u2019s disease: evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci. 2007;104:403\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"504_CR33","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1471-4159.2004.02858.x","volume":"92","author":"ES Walker","year":"2005","unstructured":"Walker ES, Martinez M, Brunkan AL, Goate A. Presenilin 2 familial Alzheimer\u2019s disease mutations result in partial loss of function and dramatic changes in A\u03b2 42\/40 ratios. J Neurochem. 2005;92:294\u2013301.","journal-title":"J Neurochem"},{"key":"504_CR34","doi-asserted-by":"publisher","first-page":"E476","DOI":"10.1073\/pnas.1618657114","volume":"114","author":"L Sun","year":"2017","unstructured":"Sun L, Zhou R, Yang G, Shi Y. Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of A\u03b242 and A\u03b240 peptides by \u03b3-secretase. Proc Natl Acad Sci. 2017;114:E476\u201385.","journal-title":"Proc Natl Acad Sci"},{"key":"504_CR35","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1001\/jama.1989.03430180093036","volume":"262","author":"DA Evans","year":"1989","unstructured":"Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, et al. Prevalence of Alzheimer\u2019s disease in a community population of older persons.Higher than previously reported. JAMA. 1989;262:2551\u20136.","journal-title":"JAMA"},{"key":"504_CR36","first-page":"205","volume":"51","author":"Z Stozick\u00e1","year":"2007","unstructured":"Stozick\u00e1 Z, Zilka N, Nov\u00e1k M. Risk and protective factors for sporadic Alzheimer\u2019s disease. Acta Virol. 2007;51:205\u201322.","journal-title":"Acta Virol"},{"key":"504_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch CM, Goate AM. Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry. 2015;77:43\u201351.","journal-title":"Biol Psychiatry"},{"key":"504_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41583-023-00776-9","volume":"25","author":"J Blumenfeld","year":"2024","unstructured":"Blumenfeld J, Yip O, Kim MJ, Huang Y. Cell type-specific roles of APOE4 in Alzheimer disease. Nat Rev Neurosci. 2024;25:91\u2013110.","journal-title":"Nat Rev Neurosci"},{"key":"504_CR39","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nrn2494","volume":"9","author":"L Bertram","year":"2008","unstructured":"Bertram L, Tanzi RE. Thirty years of Alzheimer\u2019s disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci. 2008;9:768\u201378.","journal-title":"Nat Rev Neurosci"},{"key":"504_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"EH Corder","year":"1994","unstructured":"Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180\u20134.","journal-title":"Nat Genet"},{"key":"504_CR41","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","volume":"26","author":"Q Xu","year":"2006","unstructured":"Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci Off J Soc Neurosci. 2006;26:4985\u201394.","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"504_CR42","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0002-9440(10)65305-9","volume":"154","author":"P-T Xu","year":"1999","unstructured":"Xu P-T, Gilbert JR, Qiu H-L, Ervin J, Rothrock-Christian TR, Hulette C, et al. Specific regional transcription of apolipoprotein E in human brain neurons. Am J Pathol. 1999;154:601\u201311.","journal-title":"Am J Pathol"},{"key":"504_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104724","volume":"136","author":"SA Flowers","year":"2020","unstructured":"Flowers SA, Rebeck GW. APOE in the normal brain. Neurobiol Dis. 2020;136: 104724.","journal-title":"Neurobiol Dis"},{"key":"504_CR44","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1046\/j.1471-4159.2000.0741008.x","volume":"74","author":"M Michikawa","year":"2000","unstructured":"Michikawa M, Fan Q-W, Isobe I, Yanagisawa K. Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J Neurochem. 2000;74:1008\u201316.","journal-title":"J Neurochem"},{"issue":"1","key":"504_CR45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cell.2024.10.027","volume":"88","author":"JL Guo","year":"2024","unstructured":"Guo JL, Braun D, Fitzgerald GA, Hsieh Y-T, Roug\u00e9 L, Litvinchuk A, et al. Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes. Cell. 2024;88(1):187\u2013206.","journal-title":"Cell"},{"key":"504_CR46","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/0306-4522(95)00331-C","volume":"69","author":"Z Nagy","year":"1995","unstructured":"Nagy Z, Esiri MM, Jobst KA, Johnston C, Litchfield S, Sim E, et al. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer\u2019s disease. Neuroscience. 1995;69:757\u201361.","journal-title":"Neuroscience"},{"key":"504_CR47","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261:921\u20133.","journal-title":"Science"},{"issue":"12","key":"504_CR48","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.neuron.2023.03.024","volume":"111","author":"X Hou","year":"2023","unstructured":"Hou X, Zhang X, Zou H, Guan M, Fu C, Wang W, et al. Differential and substrate-specific inhibition of \u03b3-secretase by the C-terminal region of ApoE2, ApoE3, and ApoE4. Neuron.\u00a02023;111(12):1898\u20131913.e5.","journal-title":"Neuron"},{"key":"504_CR49","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wu X, Li X, Jiang L-L, Gui X, Liu Y, et al. TREM2 is a receptor for \u03b2-amyloid that mediates microglial function. Neuron. 2018;97:1023\u20131031.e7.","journal-title":"Neuron"},{"key":"504_CR50","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molimm.2020.12.035","volume":"131","author":"R Akhter","year":"2021","unstructured":"Akhter R, Shao Y, Formica S, Khrestian M, Bekris LM. TREM2 alters the phagocytic, apoptotic and inflammatory response to A\u03b242 in HMC3 cells. Mol Immunol. 2021;131:171\u20139.","journal-title":"Mol Immunol"},{"key":"504_CR51","doi-asserted-by":"publisher","first-page":"444.e1","DOI":"10.1016\/j.neurobiolaging.2013.08.011","volume":"35","author":"A Ruiz","year":"2014","unstructured":"Ruiz A, Dols-Icardo O, Bullido MJ, Pastor P, Rodr\u00edguez-Rodr\u00edguez E, L\u00f3pez de Munain A, et al. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer\u2019s disease and frontotemporal dementia. Neurobiol Aging. 2014;35:444.e1-444.e4.","journal-title":"Neurobiol Aging"},{"key":"504_CR52","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jalz.2016.07.004","volume":"13","author":"W Song","year":"2017","unstructured":"Song W, Hooli B, Mullin K, Jin SC, Cella M, Ulland TK, et al. Alzheimer\u2019s disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation. Alzheimers Dement. 2017;13:381\u20137.","journal-title":"Alzheimers Dement"},{"key":"504_CR53","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.15252\/emmm.201707673","volume":"9","author":"P Thornton","year":"2017","unstructured":"Thornton P, Sevalle J, Deery MJ, Fraser G, Zhou Y, St\u00e5hl S, et al. TREM2 shedding by cleavage at the H157\u2013S158 bond is accelerated for the Alzheimer\u2019s disease-associated H157Y variant. EMBO Mol Med. 2017;9:1366\u201378.","journal-title":"EMBO Mol Med"},{"key":"504_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2022.167470","volume":"434","author":"EO Olufunmilayo","year":"2022","unstructured":"Olufunmilayo EO, Holsinger RMD. Variant TREM2 signaling in Alzheimer\u2019s disease. J Mol Biol. 2022;434: 167470.","journal-title":"J Mol Biol"},{"key":"504_CR55","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, Hole JT, et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med. 2016;213:667\u201375.","journal-title":"J Exp Med"},{"key":"504_CR56","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;90:724\u201339.","journal-title":"Neuron"},{"key":"504_CR57","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich JD, Ulland TK, Mahan TE, Nystr\u00f6m S, Nilsson KP, Song WM, et al. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med. 2018;215:1047\u201358.","journal-title":"J Exp Med"},{"key":"504_CR58","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256:184\u20135.","journal-title":"Science"},{"key":"504_CR59","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","volume":"120","author":"RE Tanzi","year":"2005","unstructured":"Tanzi RE, Bertram L. Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: a genetic perspective. Cell. 2005;120:545\u201355.","journal-title":"Cell"},{"key":"504_CR60","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW. Alzheimer\u2019s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984;120:885\u201390.","journal-title":"Biochem Biophys Res Commun"},{"key":"504_CR61","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3233\/JAD-190714","volume":"73","author":"X Wang","year":"2020","unstructured":"Wang X, Sun Y, Li T, Cai Y, Han Y. Amyloid-\u03b2 as a blood biomarker for Alzheimer\u2019s disease: a review of recent literature. J Alzheimers Dis JAD. 2020;73:819\u201332.","journal-title":"J Alzheimers Dis JAD"},{"key":"504_CR62","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0006-8993(01)02390-3","volume":"902","author":"H Akiyama","year":"2001","unstructured":"Akiyama H, Kondo H, Ikeda K, Kato M, McGeer PL. Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition. Brain Res. 2001;902:277\u201381.","journal-title":"Brain Res"},{"key":"504_CR63","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/jnen\/61.10.849","volume":"61","author":"M Carpentier","year":"2002","unstructured":"Carpentier M, Robitaille Y, DesGroseillers L, Boileau G, Marcinkiewicz M. Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy. J Neuropathol Exp Neurol. 2002;61:849\u201356.","journal-title":"J Neuropathol Exp Neurol"},{"key":"504_CR64","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/01.jnen.0000240463.87886.9a","volume":"65","author":"JS Miners","year":"2006","unstructured":"Miners JS, Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG. Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J Neuropathol Exp Neurol. 2006;65:1012\u201321.","journal-title":"J Neuropathol Exp Neurol"},{"key":"504_CR65","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/NEN.0b013e3181afe475","volume":"68","author":"JS Miners","year":"2009","unstructured":"Miners JS, Baig S, Tayler H, Kehoe PG, Love S. Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity. J Neuropathol Exp Neurol. 2009;68:902\u201314.","journal-title":"J Neuropathol Exp Neurol"},{"key":"504_CR66","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1194\/jlr.R075796","volume":"58","author":"M Shinohara","year":"2017","unstructured":"Shinohara M, Tachibana M, Kanekiyo T, Bu G. Role of LRP1 in the pathogenesis of Alzheimer\u2019s disease: evidence from clinical and preclinical studies. J Lipid Res. 2017;58:1267\u201381.","journal-title":"J Lipid Res"},{"key":"504_CR67","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, et al. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest. 2008;118:4002\u201313.","journal-title":"J Clin Invest"},{"key":"504_CR68","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","volume":"43","author":"R Deane","year":"2004","unstructured":"Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, et al. LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron. 2004;43:333\u201344.","journal-title":"Neuron"},{"key":"504_CR69","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1471-4159.1997.69010299.x","volume":"69","author":"Y Du","year":"1997","unstructured":"Du Y, Ni B, Glinn M, Dodel RC, Bales KR, Zhang Z, et al. alpha2-Macroglobulin as a beta-amyloid peptide-binding plasma protein. J Neurochem. 1997;69:299\u2013305.","journal-title":"J Neurochem"},{"key":"504_CR70","doi-asserted-by":"publisher","first-page":"18736","DOI":"10.1074\/jbc.M201979200","volume":"277","author":"P May","year":"2002","unstructured":"May P, Reddy YK, Herz J. Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J Biol Chem. 2002;277:18736\u201343.","journal-title":"J Biol Chem"},{"key":"504_CR71","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/07853890701214881","volume":"39","author":"P May","year":"2007","unstructured":"May P, Woldt E, Matz RL, Boucher P. The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions. Ann Med. 2007;39:219\u201328.","journal-title":"Ann Med"},{"key":"504_CR72","doi-asserted-by":"publisher","first-page":"7410","DOI":"10.1074\/jbc.275.10.7410","volume":"275","author":"PG Ulery","year":"2000","unstructured":"Ulery PG, Beers J, Mikhailenko I, Tanzi RE, Rebeck GW, Hyman BT, et al. Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer\u2019s disease. J Biol Chem. 2000;275:7410\u20135.","journal-title":"J Biol Chem"},{"key":"504_CR73","doi-asserted-by":"publisher","first-page":"15464","DOI":"10.1074\/jbc.M500613200","volume":"280","author":"JA Cam","year":"2005","unstructured":"Cam JA, Zerbinatti CV, Li Y, Bu G. Rapid endocytosis of the low density lipoprotein receptor-related protein modulates cell surface distribution and processing of the beta-amyloid precursor protein. J Biol Chem. 2005;280:15464\u201370.","journal-title":"J Biol Chem"},{"key":"504_CR74","doi-asserted-by":"publisher","first-page":"33556","DOI":"10.1074\/jbc.273.50.33556","volume":"273","author":"M Trommsdorff","year":"1998","unstructured":"Trommsdorff M, Borg JP, Margolis B, Herz J. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J Biol Chem. 1998;273:33556\u201360.","journal-title":"J Biol Chem"},{"key":"504_CR75","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1002\/alz.13692","volume":"20","author":"I Aldecoa","year":"2024","unstructured":"Aldecoa I, Barroeta I, Carroll SL, Fortea J, Gilmore A, Ginsberg SD, et al. Down syndrome biobank consortium: a perspective. Alzheimers Dement J Alzheimers Assoc. 2024;20:2262\u201372.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"504_CR76","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1038\/s41591-022-02071-z","volume":"28","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R. Amyloid-\u03b2 and tau PET scans predict clinical progression in cognitively unimpaired people. Nat Med. 2022;28:2267\u20138.","journal-title":"Nat Med"},{"key":"504_CR77","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf2362","volume":"8","author":"MR Brier","year":"2016","unstructured":"Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, et al. Tau and A\u03b2 imaging, CSF measures, and cognition in Alzheimer\u2019s disease. Sci Transl Med. 2016;8: 338ra66.","journal-title":"Sci Transl Med"},{"key":"504_CR78","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.3390\/ijms22126355","volume":"22","author":"M Tolar","year":"2021","unstructured":"Tolar M, Hey J, Power A, Abushakra S. Neurotoxic soluble amyloid oligomers drive Alzheimer\u2019s pathogenesis and represent a clinically validated target for slowing disease progression. Int J Mol Sci. 2021;22:6355.","journal-title":"Int J Mol Sci"},{"key":"504_CR79","first-page":"325","volume":"53","author":"K Iqbal","year":"1993","unstructured":"Iqbal K, Alonso A, Gong C, Khatoon S, Kudo T, Singh T, et al. Molecular pathology of Alzheimer neurofibrillary degeneration. Acta Neurobiol Exp (Warsz). 1993;53:325\u201335.","journal-title":"Acta Neurobiol Exp (Warsz)"},{"key":"504_CR80","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/1673-5374.340409","volume":"18","author":"BP Imbimbo","year":"2022","unstructured":"Imbimbo BP, Balducci C, Ippati S, Watling M. Initial failures of anti-tau antibodies in Alzheimer\u2019s disease are reminiscent of the amyloid-\u03b2 story. Neural Regen Res. 2022;18:117\u20138.","journal-title":"Neural Regen Res"},{"key":"504_CR81","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40478-021-01307-2","volume":"10","author":"M Wennstr\u00f6m","year":"2022","unstructured":"Wennstr\u00f6m M, Janelidze S, Nilsson KPR, Serrano GE, Beach TG, Dage JL, et al. Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels. Acta Neuropathol Commun. 2022;10:3.","journal-title":"Acta Neuropathol Commun"},{"key":"504_CR82","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/0896-6273(95)90232-5","volume":"14","author":"J Busciglio","year":"1995","unstructured":"Busciglio J, Lorenzo A, Yeh J, Yankner BA. Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 1995;14:879\u201388.","journal-title":"Neuron"},{"key":"504_CR83","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1006\/mcne.1997.0615","volume":"9","author":"A Ferreira","year":"1997","unstructured":"Ferreira A, Lu Q, Orecchio L, Kosik KS. Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta. Mol Cell Neurosci. 1997;9:220\u201334.","journal-title":"Mol Cell Neurosci"},{"key":"504_CR84","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13195-020-00617-2","volume":"12","author":"MS Gee","year":"2020","unstructured":"Gee MS, Son SH, Jeon SH, Do J, Kim N, Ju Y-J, et al. A selective p38\u03b1\/\u03b2 MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse. Alzheimers Res Ther. 2020;12:45.","journal-title":"Alzheimers Res Ther"},{"key":"504_CR85","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/35012636","volume":"405","author":"MS Lee","year":"2000","unstructured":"Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature. 2000;405:360\u20134.","journal-title":"Nature"},{"key":"504_CR86","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1474-9726.2009.00536.x","volume":"9","author":"JP Lopes","year":"2010","unstructured":"Lopes JP, Oliveira CR, Agostinho P. Neurodegeneration in an Abeta-induced model of Alzheimer\u2019s disease: the role of Cdk5. Aging Cell. 2010;9:64\u201377.","journal-title":"Aging Cell"},{"key":"504_CR87","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fphar.2015.00321","volume":"6","author":"R Yarza","year":"2016","unstructured":"Yarza R, Vela S, Solas M, Ramirez MJ. c-Jun N-terminal Kinase (JNK) signaling as a therapeutic target for Alzheimer\u2019s disease. Front Pharmacol. 2016;6:321.","journal-title":"Front Pharmacol"},{"key":"504_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2013.00083","volume":"4","author":"W Noble","year":"2013","unstructured":"Noble W, Hanger DP, Miller CCJ, Lovestone S. The importance of tau phosphorylation for neurodegenerative diseases. Front Neurol. 2013;4: 83.","journal-title":"Front Neurol"},{"key":"504_CR89","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0014-5793(99)00685-7","volume":"453","author":"G Alvarez","year":"1999","unstructured":"Alvarez G, Mu\u00f1oz-Monta\u00f1o JR, Satr\u00fastegui J, Avila J, Bog\u00f3nez E, D\u00edaz-Nido J. Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration. FEBS Lett. 1999;453:260\u20134.","journal-title":"FEBS Lett"},{"key":"504_CR90","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0014-4886(02)00059-6","volume":"180","author":"E Tamagno","year":"2003","unstructured":"Tamagno E, Robino G, Obbili A, Bardini P, Aragno M, Parola M, et al. H2O2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK. Exp Neurol. 2003;180:144\u201355.","journal-title":"Exp Neurol"},{"key":"504_CR91","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0306-4522(02)00404-9","volume":"115","author":"W-H Zheng","year":"2002","unstructured":"Zheng W-H, Bastianetto S, Mennicken F, Ma W, Kar S. Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience. 2002;115:201\u201311.","journal-title":"Neuroscience"},{"key":"504_CR92","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","volume":"192","author":"DJ Selkoe","year":"2008","unstructured":"Selkoe DJ. Soluble oligomers of the amyloid \u03b2-protein impair synaptic plasticity and behavior. Behav Brain Res. 2008;192:106\u201313.","journal-title":"Behav Brain Res"},{"key":"504_CR93","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1074\/jbc.271.8.4077","volume":"271","author":"YM Kuo","year":"1996","unstructured":"Kuo YM, Emmerling MR, Vigo-Pelfrey C, Kasunic TC, Kirkpatrick JB, Murdoch GH, et al. Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem. 1996;271:4077\u201381.","journal-title":"J Biol Chem"},{"key":"504_CR94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-018-0034-5","volume":"4","author":"P-P Liu","year":"2019","unstructured":"Liu P-P, Xie Y, Meng X-Y, Kang J-S. History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease. Signal Transduct Target Ther. 2019;4:1\u201322.","journal-title":"Signal Transduct Target Ther"},{"key":"504_CR95","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","volume":"378","author":"MF Egan","year":"2018","unstructured":"Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, et al. Randomized trial of Verubecestat for mild-to-moderate Alzheimer\u2019s disease. N Engl J Med. 2018;378:1691\u2013703.","journal-title":"N Engl J Med"},{"key":"504_CR96","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1001\/jamaneurol.2015.0607","volume":"72","author":"V Coric","year":"2015","unstructured":"Coric V, Salloway S, van Dyck CH, Dubois B, Andreasen N, Brody M, et al. Targeting prodromal Alzheimer disease with avagacestat: a randomized clinical trial. JAMA Neurol. 2015;72:1324\u201333.","journal-title":"JAMA Neurol"},{"key":"504_CR97","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamaneurol.2020.4857","volume":"78","author":"R Sperling","year":"2021","unstructured":"Sperling R, Henley D, Aisen PS, Raman R, Donohue MC, Ernstrom K, et al. Findings of efficacy, safety, and biomarker outcomes of atabecestat in preclinical Alzheimer disease: a truncated randomized phase 2b\/3 clinical trial. JAMA Neurol. 2021;78:293\u2013301.","journal-title":"JAMA Neurol"},{"key":"504_CR98","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1210951","volume":"369","author":"RS Doody","year":"2013","unstructured":"Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, et al. A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease. N Engl J Med. 2013;369:341\u201350.","journal-title":"N Engl J Med"},{"key":"504_CR99","doi-asserted-by":"publisher","first-page":"197","DOI":"10.14283\/jpad.2022.30","volume":"9","author":"S Budd Haeberlein","year":"2022","unstructured":"Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, et al. Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease. J Prev Alzheimers Dis. 2022;9:197\u2013210.","journal-title":"J Prev Alzheimers Dis"},{"key":"504_CR100","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3233\/JAD-220262","volume":"87","author":"P Whitehouse","year":"2022","unstructured":"Whitehouse P, Gandy S, Saini V, George DR, Larson EB, Alexander GC, et al. Making the case for accelerated withdrawal of aducanumab. J Alzheimers Dis JAD. 2022;87:1003\u20137.","journal-title":"J Alzheimers Dis JAD"},{"key":"504_CR101","unstructured":"Aduhelm | European Medicines Agency.. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/aduhelm"},{"key":"504_CR102","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13195-017-0318-y","volume":"9","author":"S Ostrowitzki","year":"2017","unstructured":"Ostrowitzki S, Lasser RA, Dorflinger E, Scheltens P, Barkhof F, Nikolcheva T, et al. A phase III randomized trial of gantenerumab in prodromal Alzheimer\u2019s disease. Alzheimers Res Ther. 2017;9:95.","journal-title":"Alzheimers Res Ther"},{"key":"504_CR103","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/jamaneurol.2021.5205","volume":"79","author":"M Filippi","year":"2022","unstructured":"Filippi M, Cecchetti G, Spinelli EG, Vezzulli P, Falini A, Agosta F. Amyloid-related imaging abnormalities and \u03b2-amyloid-targeting antibodies: a systematic review. JAMA Neurol. 2022;79:291\u2013304.","journal-title":"JAMA Neurol"},{"key":"504_CR104","doi-asserted-by":"publisher","first-page":"562","DOI":"10.2214\/AJR.22.28461","volume":"220","author":"M Roytman","year":"2023","unstructured":"Roytman M, Mashriqi F, Al-Tawil K, Schulz PE, Zaharchuk G, Benzinger TLS, et al. Amyloid-related imaging abnormalities: an update. Am J Roentgenol. 2023;220:562\u201374.","journal-title":"Am J Roentgenol"},{"key":"504_CR105","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","volume":"79","author":"S Salloway","year":"2022","unstructured":"Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, et al. Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol. 2022;79:13\u201321.","journal-title":"JAMA Neurol"},{"key":"504_CR106","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"504_CR107","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330:512\u201327.","journal-title":"JAMA"},{"key":"504_CR108","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","volume":"13","author":"CJ Swanson","year":"2021","unstructured":"Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, et al. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-A\u03b2 protofibril antibody. Alzheimers Res Ther. 2021;13:80.","journal-title":"Alzheimers Res Ther"},{"key":"504_CR109","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-025-00465-w","volume":"14","author":"B-H Kim","year":"2025","unstructured":"Kim B-H, Kim S, Nam Y, Park YH, Shin SM, Moon M. Second-generation anti-amyloid monoclonal antibodies for Alzheimer\u2019s disease: current landscape and future perspectives. Transl Neurodegener. 2025;14:6.","journal-title":"Transl Neurodegener"},{"key":"504_CR110","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012778","volume":"97","author":"L Antolini","year":"2021","unstructured":"Antolini L, DiFrancesco JC, Zedde M, Basso G, Arighi A, Shima A, et al. Spontaneous ARIA-like events in cerebral amyloid angiopathy\u2013related inflammation: a multicenter prospective longitudinal cohort study. Neurology. 2021;97: e1809.","journal-title":"Neurology"},{"key":"504_CR111","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Jack CR, Black SE, Frosch MP, Greenberg SM, Hyman BT, et al. Amyloid related imaging abnormalities (aria) in amyloid modifying therapeutic trials: recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup. Alzheimers Dement J Alzheimers Assoc. 2011;7:367\u201385.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"504_CR112","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1212\/WNL.0b013e31820e773c","volume":"76","author":"JC DiFrancesco","year":"2011","unstructured":"DiFrancesco JC, Brioschi M, Brighina L, Ruffmann C, Saracchi E, Costantino G, et al. Anti-A\u03b2 autoantibodies in the CSF of a patient with CAA-related inflammation: a case report. Neurology. 2011;76:842\u20134.","journal-title":"Neurology"},{"key":"504_CR113","unstructured":"Scientists tie third clinical trial death to experimental Alzheimer\u2019s drug.. Available from: https:\/\/www.science.org\/content\/article\/scientists-tie-third-clinical-trial-death-experimental-alzheimer-s-drug"},{"key":"504_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110173","volume":"367","author":"K Jomova","year":"2022","unstructured":"Jomova K, Makova M, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, et al. Essential metals in health and disease. Chem Biol Interact. 2022;367: 110173.","journal-title":"Chem Biol Interact"},{"key":"504_CR115","first-page":"33","volume-title":"The functional roles of metals in metalloenzymes. Protein-Met Interact","author":"JF Riordan","year":"1974","unstructured":"Riordan JF, Vallee BL. The functional roles of metals in metalloenzymes. Protein-Met Interact. Boston: Springer; 1974. p. 33\u201357."},{"key":"504_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101619","volume":"77","author":"R Bai","year":"2022","unstructured":"Bai R, Guo J, Ye X-Y, Xie Y, Xie T. Oxidative stress: The core pathogenesis and mechanism of Alzheimer\u2019s disease. Ageing Res Rev. 2022;77: 101619.","journal-title":"Ageing Res Rev"},{"key":"504_CR117","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","volume":"14","author":"C Cheignon","year":"2017","unstructured":"Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F. Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol. 2017;14:450\u201364.","journal-title":"Redox Biol"},{"key":"504_CR118","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","volume":"158","author":"MA Lovell","year":"1998","unstructured":"Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron and zinc in Alzheimer\u2019s disease senile plaques. J Neurol Sci. 1998;158:47\u201352.","journal-title":"J Neurol Sci"},{"key":"504_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"T Guo","year":"2020","unstructured":"Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol Neurodegener. 2020;15: 40.","journal-title":"Mol Neurodegener"},{"key":"504_CR120","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jsb.2005.09.004","volume":"155","author":"LM Miller","year":"2006","unstructured":"Miller LM, Wang Q, Telivala TP, Smith RJ, Lanzirotti A, Miklossy J. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer\u2019s disease. J Struct Biol. 2006;155:30\u20137.","journal-title":"J Struct Biol"},{"key":"504_CR121","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.pneurobio.2011.05.001","volume":"94","author":"M Schrag","year":"2011","unstructured":"Schrag M, Mueller C, Oyoyo U, Smith MA, Kirsch WM. Iron, zinc and copper in the Alzheimer\u2019s disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion. Prog Neurobiol. 2011;94:296\u2013306.","journal-title":"Prog Neurobiol"},{"key":"504_CR122","doi-asserted-by":"publisher","DOI":"10.1177\/1759091420962681","volume":"12","author":"VT Cheli","year":"2020","unstructured":"Cheli VT, Correale J, Paez PM, Pasquini JM. Iron metabolism in oligodendrocytes and astrocytes, implications for myelination and remyelination. ASN Neuro. 2020;12: 1759091420962681.","journal-title":"ASN Neuro"},{"key":"504_CR123","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0736-5748(88)90042-1","volume":"6","author":"A Espinosa de los Monteros","year":"1988","unstructured":"Espinosa de los Monteros A, Chiapelli F, Fisher RS, de Vellis J. Transferrin: an early marker of oligodendrocytes in culture. Int J Dev Neurosci Off J Int Soc Dev Neurosci. 1988;6:167\u201375.","journal-title":"Int J Dev Neurosci Off J Int Soc Dev Neurosci."},{"key":"504_CR124","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/jnr.490310111","volume":"31","author":"JR Connor","year":"1992","unstructured":"Connor JR, Menzies SL, St. Martin SM, Mufson EJ. A histochemical study of iron, transferrin, and ferritin in Alzheimer\u2019s diseased brains. J Neurosci Res. 1992;31:75\u201383.","journal-title":"J Neurosci Res"},{"key":"504_CR125","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF00334497","volume":"81","author":"I Grundke-Iqbal","year":"1990","unstructured":"Grundke-Iqbal I, Fleming J, Tung Y-C, Lassmann H, Iqbal K, Joshi JG. Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol (Berl). 1990;81:105\u201310.","journal-title":"Acta Neuropathol (Berl)"},{"key":"504_CR126","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1046\/j.1471-4159.1995.64010307.x","volume":"64","author":"S Bodovitz","year":"1995","unstructured":"Bodovitz S, Falduto MT, Frail DE, Klein WL. Iron levels modulate alpha-secretase cleavage of amyloid precursor protein. J Neurochem. 1995;64:307\u201315.","journal-title":"J Neurochem"},{"key":"504_CR127","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/aps.2017.113","volume":"39","author":"Y Chen","year":"2018","unstructured":"Chen Y, Chen W, Huang X, Xu Y, Zhang H. Iron dysregulates APP processing accompanying with sAPP\u03b1 cellular retention and \u03b2-secretase inhibition in rat cortical neurons. Acta Pharmacol Sin. 2018;39:177\u201383.","journal-title":"Acta Pharmacol Sin"},{"key":"504_CR128","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1042\/BST0361282","volume":"36","author":"J Rogers","year":"2008","unstructured":"Rogers J, Bush A, Cho H-H, Smith D, Thomson A, Friedlich A, et al. Iron and the translation of the amyloid precursor protein (APP) and ferritin. Biochem Soc Trans. 2008;36:1282\u20137.","journal-title":"Biochem Soc Trans"},{"key":"504_CR129","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.cell.2010.08.014","volume":"142","author":"JA Duce","year":"2010","unstructured":"Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, et al. Iron-export ferroxidase activity of \u03b2-amyloid precursor protein is inhibited by zinc in Alzheimer\u2019s disease. Cell. 2010;142:857\u201367.","journal-title":"Cell"},{"key":"504_CR130","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s11064-019-02747-y","volume":"44","author":"A Tsatsanis","year":"2019","unstructured":"Tsatsanis A, Dickens S, Kwok JCF, Wong BX, Duce JA. Post translational modulation of \u03b2-amyloid precursor protein trafficking to the cell surface alters neuronal iron homeostasis. Neurochem Res. 2019;44:1367\u201374.","journal-title":"Neurochem Res"},{"key":"504_CR131","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrn1537","volume":"5","author":"L Zecca","year":"2004","unstructured":"Zecca L, Youdim MBH, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci. 2004;5:863\u201373.","journal-title":"Nat Rev Neurosci"},{"key":"504_CR132","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/alz.12282","volume":"17","author":"S Ayton","year":"2021","unstructured":"Ayton S, Portbury S, Kalinowski P, Agarwal P, Diouf I, Schneider JA, et al. Regional brain iron associated with deterioration in Alzheimer\u2019s disease: a large cohort study and theoretical significance. Alzheimers Dement. 2021;17:1244\u201356.","journal-title":"Alzheimers Dement"},{"key":"504_CR133","doi-asserted-by":"publisher","first-page":"500","DOI":"10.2174\/156720508786898479","volume":"5","author":"D Drago","year":"2008","unstructured":"Drago D, Bolognin S, Zatta P. Role of metal ions in the A\u03b2 oligomerization in Alzheimers disease and in other neurological disorders. Curr Alzheimer Res. 2008;5:500\u20137.","journal-title":"Curr Alzheimer Res"},{"key":"504_CR134","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.bpj.2011.06.062","volume":"101","author":"N Rezaei-Ghaleh","year":"2011","unstructured":"Rezaei-Ghaleh N, Giller K, Becker S, Zweckstetter M. Effect of zinc binding on \u03b2-amyloid structure and dynamics: implications for A\u03b2 aggregation. Biophys J. 2011;101:1202\u201311.","journal-title":"Biophys J"},{"key":"504_CR135","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1039\/c3mt00161j","volume":"5","author":"AK Sharma","year":"2013","unstructured":"Sharma AK, Pavlova ST, Kim J, Kim J, Mirica LM. The effect of Cu2+ and Zn2+ on the A\u03b242 peptide aggregation and cellular toxicity. Metallomics. 2013;5:1529\u201336.","journal-title":"Metallomics"},{"key":"504_CR136","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3233\/JAD-180151","volume":"64","author":"KM Craven","year":"2018","unstructured":"Craven KM, Kochen WR, Hernandez CM, Flinn JM. Zinc exacerbates tau pathology in a tau mouse model. J Alzheimers Dis JAD. 2018;64:617\u201330.","journal-title":"J Alzheimers Dis JAD"},{"issue":"3","key":"504_CR137","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.celrep.2014.06.047","volume":"8","author":"Y Huang","year":"2014","unstructured":"Huang Y, Wu Z, Cao Y, Lang M, Lu B, Zhou B. Zinc binding directly regulates tau toxicity independent of tau hyperphosphorylation. Cell Rep. 2014;8(3):831\u201342.","journal-title":"Cell Rep"},{"key":"504_CR138","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.brainresbull.2008.03.014","volume":"77","author":"L-H Zhang","year":"2008","unstructured":"Zhang L-H, Wang X, Stoltenberg M, Danscher G, Huang L, Wang Z-Y. Abundant expression of zinc transporters in the amyloid plaques of Alzheimer\u2019s disease brain. Brain Res Bull. 2008;77:55\u201360.","journal-title":"Brain Res Bull"},{"key":"504_CR139","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/BF03033884","volume":"7","author":"MA Lovell","year":"2005","unstructured":"Lovell MA, Smith JL, Xiong S, Markesbery WR. Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer\u2019s disease. Neurotox Res. 2005;7:265\u201371.","journal-title":"Neurotox Res"},{"key":"504_CR140","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1750-3639.2009.00283.x","volume":"20","author":"G Lyubartseva","year":"2010","unstructured":"Lyubartseva G, Smith JL, Markesbery WR, Lovell MA. Alterations of zinc transporter proteins ZnT-1, ZnT-4 and ZnT-6 in preclinical Alzheimer\u2019s disease brain. Brain Pathol Zurich Switz. 2010;20:343\u201350.","journal-title":"Brain Pathol Zurich Switz"},{"key":"504_CR141","doi-asserted-by":"publisher","first-page":"7705","DOI":"10.1073\/pnas.092034699","volume":"99","author":"J-Y Lee","year":"2002","unstructured":"Lee J-Y, Cole TB, Palmiter RD, Suh SW, Koh J-Y. Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci U S A. 2002;99:7705\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"504_CR142","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3389\/fnagi.2017.00300","volume":"9","author":"D-D Li","year":"2017","unstructured":"Li D-D, Zhang W, Wang Z-Y, Zhao P. Serum copper, zinc, and iron levels in patients with Alzheimer\u2019s disease: a meta-analysis of case-control studies. Front Aging Neurosci. 2017;9:300.","journal-title":"Front Aging Neurosci"},{"key":"504_CR143","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JAD-141296","volume":"46","author":"M Ventriglia","year":"2015","unstructured":"Ventriglia M, Brewer GJ, Simonelli I, Mariani S, Siotto M, Bucossi S, et al. Zinc in Alzheimer\u2019s disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies. J Alzheimers Dis. 2015;46:75\u201387.","journal-title":"J Alzheimers Dis JAD"},{"key":"504_CR144","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S1357-2725(02)00134-6","volume":"35","author":"PA Sharp","year":"2003","unstructured":"Sharp PA. Ctr1 and its role in body copper homeostasis. Int J Biochem Cell Biol. 2003;35:288\u201391.","journal-title":"Int J Biochem Cell Biol"},{"key":"504_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2020.213727","volume":"433","author":"E Falcone","year":"2021","unstructured":"Falcone E, Okafor M, Vitale N, Raibaut L, Sour A, Faller P. Extracellular Cu2+ pools and their detection: from current knowledge to next-generation probes. Coord Chem Rev. 2021;433: 213727.","journal-title":"Coord Chem Rev"},{"key":"504_CR146","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.biocel.2009.11.007","volume":"42","author":"S La Fontaine","year":"2010","unstructured":"La Fontaine S, Ackland ML, Mercer JFB. Mammalian copper-transporting P-type ATPases, ATP7A and ATP7B: emerging roles. Int J Biochem Cell Biol. 2010;42:206\u20139.","journal-title":"Int J Biochem Cell Biol"},{"key":"504_CR147","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/antiox5030025","volume":"5","author":"Y Hatori","year":"2016","unstructured":"Hatori Y, Lutsenko S. The role of copper chaperone Atox1 in coupling redox homeostasis to intracellular copper distribution. Antioxidants. 2016;5:25.","journal-title":"Antioxidants"},{"key":"504_CR148","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1152\/physrev.00004.2006","volume":"87","author":"S Lutsenko","year":"2007","unstructured":"Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY. Function and regulation of human copper-transporting ATPases. Physiol Rev. 2007;87:1011\u201346.","journal-title":"Physiol Rev"},{"key":"504_CR149","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.biocel.2009.06.008","volume":"41","author":"NA Veldhuis","year":"2009","unstructured":"Veldhuis NA, Valova VA, Gaeth AP, Palstra N, Hannan KM, Michell BJ, et al. Phosphorylation regulates copper-responsive trafficking of the Menkes copper transporting P-type ATPase. Int J Biochem Cell Biol. 2009;41:2403\u201312.","journal-title":"Int J Biochem Cell Biol"},{"key":"504_CR150","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neuint.2015.07.006","volume":"90","author":"N D\u2019Ambrosi","year":"2015","unstructured":"D\u2019Ambrosi N, Rossi L. Copper at synapse: release, binding and modulation of neurotransmission. Neurochem Int. 2015;90:36\u201345.","journal-title":"Neurochem Int"},{"key":"504_CR151","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fnagi.2013.00044","volume":"5","author":"J Telianidis","year":"2013","unstructured":"Telianidis J, Hung YH, Materia S, Fontaine SL. Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis. Front Aging Neurosci. 2013;5:44.","journal-title":"Front Aging Neurosci"},{"key":"504_CR152","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1242\/jcs.043216","volume":"122","author":"C White","year":"2009","unstructured":"White C, Kambe T, Fulcher YG, Sachdev SW, Bush AI, Fritsche K, et al. Copper transport into the secretory pathway is regulated by oxygen in macrophages. J Cell Sci. 2009;122:1315\u201321.","journal-title":"J Cell Sci"},{"key":"504_CR153","first-page":"334","volume":"20","author":"Z Qin","year":"2006","unstructured":"Qin Z, Itoh S, Jeney V, Ushio-Fukai M, Fukai T. Essential role for the Menkes ATPase in activation of extracellular superoxide dismutase: implication for vascular oxidative stress. FASEB J Off Publ Fed Am Soc Exp Biol. 2006;20:334\u20136.","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"504_CR154","doi-asserted-by":"publisher","first-page":"G1181","DOI":"10.1152\/ajpgi.00472.2006","volume":"292","author":"L Nyasae","year":"2007","unstructured":"Nyasae L, Bustos R, Braiterman L, Eipper B, Hubbard A. Dynamics of endogenous ATP7A (Menkes protein) in intestinal epithelial cells: copper-dependent redistribution between two intracellular sites. Am J Physiol-Gastrointest Liver Physiol. 2007;292:G1181\u201394.","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"504_CR155","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1469-7580.2008.00954.x","volume":"213","author":"KH Weiss","year":"2008","unstructured":"Weiss KH, Wurz J, Gotthardt D, Merle U, Stremmel W, F\u00fcllekrug J. Localization of the Wilson disease protein in murine intestine. J Anat. 2008;213:232\u201340.","journal-title":"J Anat"},{"key":"504_CR156","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.devcel.2014.04.033","volume":"29","author":"EV Polishchuk","year":"2014","unstructured":"Polishchuk EV, Concilli M, Iacobacci S, Chesi G, Pastore N, Piccolo P, et al. Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis. Dev Cell. 2014;29:686\u2013700.","journal-title":"Dev Cell"},{"key":"504_CR157","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fnagi.2014.00143","volume":"6","author":"CM Opazo","year":"2014","unstructured":"Opazo CM, Greenough MA, Bush AI. Copper: from neurotransmission to neuroproteostasis. Front Aging Neurosci. 2014;6:143.","journal-title":"Front Aging Neurosci."},{"key":"504_CR158","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1039\/c0mt00006j","volume":"2","author":"S Lutsenko","year":"2010","unstructured":"Lutsenko S, Bhattacharjee A, Hubbard AL. Copper handling machinery of the brain. Metallomics. 2010;2:596\u2013608.","journal-title":"Metallomics"},{"key":"504_CR159","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1073\/pnas.0403495101","volume":"101","author":"L Zecca","year":"2004","unstructured":"Zecca L, Stroppolo A, Gatti A, Tampellini D, Toscani M, Gallorini M, et al. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci U S A. 2004;101:9843\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"504_CR160","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1039\/C2MT20151H","volume":"5","author":"KM Davies","year":"2013","unstructured":"Davies KM, Hare DJ, Cottam V, Chen N, Hilgers L, Halliday G, et al. Localization of copper and copper transporters in the human brain\u2020. Metallomics. 2013;5(1):43\u201351.","journal-title":"Metallomics"},{"key":"504_CR161","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2174\/0929867324666171026163144","volume":"25","author":"G Trapani","year":"2018","unstructured":"Trapani G, Satriano C, Mendola DL. Peptides and their metal complexes in neurodegenerative diseases: from structural studies to nanomedicine prospects. Curr Med Chem. 2018;25:715\u201347.","journal-title":"Curr Med Chem"},{"key":"504_CR162","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072341","volume":"21","author":"B Witt","year":"2020","unstructured":"Witt B, Schauml\u00f6ffel D, Schwerdtle T. Subcellular localization of copper\u2014cellular bioimaging with focus on neurological disorders. Int J Mol Sci. 2020;21: 2341.","journal-title":"Int J Mol Sci"},{"key":"504_CR163","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1021\/acschemneuro.6b00452","volume":"8","author":"L Perrin","year":"2017","unstructured":"Perrin L, Roudeau S, Carmona A, Domart F, Petersen JD, Bohic S, et al. Zinc and copper effects on stability of tubulin and actin networks in dendrites and spines of hippocampal neurons. ACS Chem Neurosci. 2017;8:1490\u20139.","journal-title":"ACS Chem Neurosci"},{"key":"504_CR164","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jmb.2011.12.057","volume":"416","author":"SO Dahms","year":"2012","unstructured":"Dahms SO, K\u00f6nnig I, Roeser D, G\u00fchrs K-H, Mayer MC, Kaden D, et al. Metal binding dictates conformation and function of the amyloid precursor protein (APP) E2 domain. J Mol Biol. 2012;416:438\u201352.","journal-title":"J Mol Biol"},{"key":"504_CR165","doi-asserted-by":"publisher","first-page":"8252","DOI":"10.1074\/jbc.M110.128512","volume":"286","author":"KM Acevedo","year":"2011","unstructured":"Acevedo KM, Hung YH, Dalziel AH, Li Q-X, Laughton K, Wikhe K, et al. Copper promotes the trafficking of the amyloid precursor protein. J Biol Chem. 2011;286:8252\u201362.","journal-title":"J Biol Chem"},{"key":"504_CR166","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0006-8993(99)01861-2","volume":"842","author":"AR White","year":"1999","unstructured":"White AR, Reyes R, Mercer JFB, Camakaris J, Zheng H, Bush AI, et al. Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res. 1999;842:439\u201344.","journal-title":"Brain Res"},{"key":"504_CR167","doi-asserted-by":"publisher","first-page":"7609","DOI":"10.1021\/bi990438f","volume":"38","author":"X Huang","year":"1999","unstructured":"Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, et al. The A\u03b2 peptide of Alzheimer\u2019s disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry. 1999;38:7609\u201316.","journal-title":"Biochemistry"},{"key":"504_CR168","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1039\/d0mt00048e","volume":"12","author":"M Scholefield","year":"2020","unstructured":"Scholefield M, Church SJ, Xu J, Kassab S, Gardiner NJ, Roncaroli F, et al. Evidence that levels of nine essential metals in post-mortem human-Alzheimer\u2019s-brain and ex vivo rat-brain tissues are unaffected by differences in post-mortem delay, age, disease staging, and brain bank location\u2020. Metallomics. 2020;12:952\u201362.","journal-title":"Metallomics"},{"key":"504_CR169","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-020-00189-z","volume":"9","author":"L Wang","year":"2020","unstructured":"Wang L, Yin Y-L, Liu X-Z, Shen P, Zheng Y-G, Lan X-R, et al. Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease. Transl Neurodegener. 2020;9: 10.","journal-title":"Transl Neurodegener"},{"issue":"2","key":"504_CR170","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2011.10.446","volume":"52","author":"SA James","year":"2012","unstructured":"James SA, Volitakis I, Adlard PA, Duce JA, Masters CL, Cherny RA, et al. Elevated labile Cu is associated with oxidative pathology in Alzheimer disease. Free Radic Biol Med. 2012;52(2):298\u2013302.","journal-title":"Free Radic Biol Med"},{"key":"504_CR171","volume":"2013","author":"A Rembach","year":"2013","unstructured":"Rembach A, Hare DJ, Lind M, Fowler CJ, Cherny RA, McLean C, et al. Decreased copper in Alzheimer\u2019s disease brain is predominantly in the soluble extractable fraction. Int J Alzheimer\u2019s Dis. 2013;2013:e623241.","journal-title":"Int J Alzheimer\u2019s Dis"},{"issue":"7","key":"504_CR172","doi-asserted-by":"publisher","first-page":"6377","DOI":"10.3390\/ijms24076377","volume":"24","author":"R Squitti","year":"2023","unstructured":"Squitti R, Catalli C, Gigante L, Marianetti M, Rosari M, Mariani S, et al. Non-ceruloplasmin copper identifies a subtype of Alzheimer\u2019s disease (CuAD): characterization of the cognitive profile and case of a CuAD patient carrying an RGS7 stop-loss variant. Int J Mol Sci. 2023;24(7):6377.","journal-title":"Int J Mol Sci"},{"key":"504_CR173","doi-asserted-by":"publisher","DOI":"10.3390\/biom11070960","volume":"11","author":"R Squitti","year":"2021","unstructured":"Squitti R, Ventriglia M, Simonelli I, Bonvicini C, Costa A, Perini G, et al. Copper imbalance in Alzheimer\u2019s disease: meta-analysis of serum, plasma, and brain specimens, and replication study evaluating ATP7B gene variants. Biomolecules. 2021;11: 960.","journal-title":"Biomolecules"},{"key":"504_CR174","doi-asserted-by":"publisher","first-page":"11065","DOI":"10.1073\/pnas.1832769100","volume":"100","author":"DL Sparks","year":"2003","unstructured":"Sparks DL, Schreurs BG. Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2003;100:11065\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"504_CR175","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1074\/jbc.M116.756163","volume":"292","author":"SW Mercer","year":"2017","unstructured":"Mercer SW, Wang J, Burke R. In vivo modeling of the pathogenic effect of copper transporter mutations that cause Menkes and Wilson diseases, motor neuropathy, and susceptibility to Alzheimer\u2019s disease. J Biol Chem. 2017;292:4113\u201322.","journal-title":"J Biol Chem"},{"key":"504_CR176","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12017-013-8237-y","volume":"15","author":"R Squitti","year":"2013","unstructured":"Squitti R, Polimanti R, Siotto M, Bucossi S, Ventriglia M, Mariani S, et al. ATP7B variants as modulators of copper dyshomeostasis in Alzheimer\u2019s disease. NeuroMolecular Med. 2013;15:515\u201322.","journal-title":"NeuroMolecular Med"},{"key":"504_CR177","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.parkreldis.2019.02.016","volume":"59","author":"P Hedera","year":"2019","unstructured":"Hedera P. Wilson\u2019s disease: a master of disguise. Parkinsonism Relat Disord. 2019;59:140\u20135.","journal-title":"Parkinsonism Relat Disord"},{"key":"504_CR178","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jceh.2018.08.009","volume":"9","author":"A Nagral","year":"2019","unstructured":"Nagral A, Sarma MS, Matthai J, Kukkle PL, Devarbhavi H, Sinha S, et al. Wilson\u2019s disease: clinical practice guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India. J Clin Exp Hepatol. 2019;9:74\u201398.","journal-title":"J Clin Exp Hepatol"},{"key":"504_CR179","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/jimd.12046","volume":"42","author":"J Pfeiffenberger","year":"2019","unstructured":"Pfeiffenberger J, Lohse CM, Gotthardt D, Rupp C, Weiler M, Teufel U, et al. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment. J Inherit Metab Dis. 2019;42:371\u201380.","journal-title":"J Inherit Metab Dis"},{"key":"504_CR180","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3233\/JAD-2010-101473","volume":"24","author":"S Bucossi","year":"2011","unstructured":"Bucossi S, Ventriglia M, Panetta V, Salustri C, Pasqualetti P, Mariani S, et al. Copper in Alzheimer\u2019s disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studies. J Alzheimers Dis JAD. 2011;24:175\u201385.","journal-title":"J Alzheimers Dis JAD"},{"key":"504_CR181","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10534-007-9125-4","volume":"21","author":"CR Capo","year":"2008","unstructured":"Capo CR, Arciello M, Squitti R, Cassetta E, Rossini PM, Calabrese L, et al. Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer\u2019s disease patients. Biometals. 2008;21:367\u201372.","journal-title":"Biometals"},{"key":"504_CR182","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1034\/j.1600-0773.2001.d01-168.x","volume":"89","author":"G T\u00f3rsd\u00f3ttir","year":"2001","unstructured":"T\u00f3rsd\u00f3ttir G, Kristinsson J, Hreidarsson S, Snaedal J, J\u00f3hannesson T. Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down\u2019s syndrome. Pharmacol Toxicol. 2001;89:320\u20135.","journal-title":"Pharmacol Toxicol"},{"key":"504_CR183","doi-asserted-by":"publisher","first-page":"27144","DOI":"10.1074\/jbc.M301988200","volume":"278","author":"SY Jeong","year":"2003","unstructured":"Jeong SY, David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem. 2003;278:27144\u20138.","journal-title":"J Biol Chem"},{"key":"504_CR184","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1039\/C4MT00001C","volume":"6","author":"TR Young","year":"2014","unstructured":"Young TR, Kirchner A, Wedd AG, Xiao Z. An integrated study of the affinities of the A\u03b216 peptide for Cu(I) and Cu(II): implications for the catalytic production of reactive oxygen species. Metallomics. 2014;6:505\u201317.","journal-title":"Metallomics"},{"key":"504_CR185","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1021\/acs.analchem.6b04979","volume":"89","author":"A Conte-Daban","year":"2017","unstructured":"Conte-Daban A, Borghesani V, Sayen S, Guillon E, Journaux Y, Gontard G, et al. Link between affinity and Cu(II) binding sites to amyloid-\u03b2 peptides evaluated by a new water-soluble UV-visible ratiometric dye with a moderate Cu(II) affinity. Anal Chem. 2017;89:2155\u201362.","journal-title":"Anal Chem"},{"key":"504_CR186","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1021\/bi900254n","volume":"48","author":"CJ Sarell","year":"2009","unstructured":"Sarell CJ, Syme CD, Rigby SEJ, Viles JH. Copper(II) binding to amyloid-beta fibrils of Alzheimer\u2019s disease reveals a picomolar affinity: stoichiometry and coordination geometry are independent of Abeta oligomeric form. Biochemistry. 2009;48:4388\u2013402.","journal-title":"Biochemistry"},{"key":"504_CR187","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ccr.2018.04.007","volume":"371","author":"E Atri\u00e1n-Blasco","year":"2018","unstructured":"Atri\u00e1n-Blasco E, Gonzalez P, Santoro A, Alies B, Faller P, Hureau C. Cu and Zn coordination to amyloid peptides: from fascinating chemistry to debated pathological relevance. Coord Chem Rev. 2018;371:38\u201355.","journal-title":"Coord Chem Rev"},{"key":"504_CR188","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1002\/cbic.200900321","volume":"10","author":"P Faller","year":"2009","unstructured":"Faller P. Copper and zinc binding to Amyloid-\u03b2: coordination, dynamics, aggregation, reactivity and metal-ion transfer. ChemBioChem. 2009;10:2837\u201345.","journal-title":"ChemBioChem"},{"key":"504_CR189","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1021\/ja808073b","volume":"131","author":"SC Drew","year":"2009","unstructured":"Drew SC, Noble CJ, Masters CL, Hanson GR, Barnham KJ. Pleomorphic copper coordination by Alzheimer\u2019s disease amyloid-beta peptide. J Am Chem Soc. 2009;131:1195\u2013207.","journal-title":"J Am Chem Soc"},{"key":"504_CR190","doi-asserted-by":"publisher","first-page":"9273","DOI":"10.1002\/anie.200904567","volume":"48","author":"P Dorlet","year":"2009","unstructured":"Dorlet P, Gambarelli S, Faller P, Hureau C. Pulse EPR spectroscopy reveals the coordination sphere of copper(ii) ions in the 1\u201316 amyloid-\u03b2 peptide: a key role of the first two N-terminus residues. Angew Chem Int Ed. 2009;48:9273\u20136.","journal-title":"Angew Chem Int Ed"},{"key":"504_CR191","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jinorgbio.2014.03.018","volume":"137","author":"AN Pham","year":"2014","unstructured":"Pham AN, Waite TD. Cu(II)-catalyzed oxidation of dopamine in aqueous solutions: mechanism and kinetics. J Inorg Biochem. 2014;137:74\u201384.","journal-title":"J Inorg Biochem"},{"key":"504_CR192","unstructured":"Falcone E, Nobili G, Okafor M, Proux O, Rossi G, Morante S, et al. Chasing the Elusive \u201cIn-Between\u201d State of the Copper-Amyloid\u03b2 Complex by X-ray Absorption through Partial Thermal Relaxation after Photoreduction. Angew Chem Int Ed.;n\/a:e202217791."},{"key":"504_CR193","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ica.2017.07.031","volume":"472","author":"C Cheignon","year":"2018","unstructured":"Cheignon C, Hureau C, Collin F. Real-time evolution of A\u03b240 metal-catalyzed oxidation reveals Asp1 as the main target and a dependence on metal binding site. Inorganica Chim Acta. 2018;472:111\u20138.","journal-title":"Inorganica Chim Acta"},{"key":"504_CR194","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-61779-551-0_1","volume-title":"Amyloid proteins methods protoc","author":"AP Gunn","year":"2012","unstructured":"Gunn AP, Roberts BR, Bush AI. Rapid generation of dityrosine cross-linked A\u03b2 oligomers via Cu-redox cycling. In: Sigurdsson EM, Calero M, Gasset M, editors. Amyloid Proteins: Methods and Protocols. Totowa, NJ: Humana Press; 2012;p. 3\u201310."},{"key":"504_CR195","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1021\/bi0358824","volume":"43","author":"CS Atwood","year":"2004","unstructured":"Atwood CS, Perry G, Zeng H, Kato Y, Jones WD, Ling K-Q, et al. Copper mediates dityrosine cross-linking of Alzheimer\u2019s amyloid-\u03b2. Biochemistry. 2004;43:560\u20138.","journal-title":"Biochemistry"},{"key":"504_CR196","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1042\/BJ20141168","volume":"466","author":"CJ Matheou","year":"2015","unstructured":"Matheou CJ, Younan ND, Viles JH. Cu2+ accentuates distinct misfolding of A\u03b2(1\u201340) and A\u03b2(1\u201342) peptides, and potentiates membrane disruption. Biochem J. 2015;466:233\u201342.","journal-title":"Biochem J"},{"key":"504_CR197","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1021\/jacsau.3c00687","volume":"4","author":"Y Tian","year":"2024","unstructured":"Tian Y, Shang Q, Liang R, Viles JH. Copper(II) can kinetically trap arctic and Italian amyloid-\u03b240 as toxic oligomers, mimicking Cu(II) binding to wild-type amyloid-\u03b242: implications for familial Alzheimer\u2019s disease. JACS Au. 2024;4:578\u201391.","journal-title":"JACS Au"},{"key":"504_CR198","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00775-019-01727-5","volume":"24","author":"MGM Weibull","year":"2019","unstructured":"Weibull MGM, Simonsen S, Oksbjerg CR, Tiwari MK, Hemmingsen L. Effects of Cu(II) on the aggregation of amyloid-\u03b2. J Biol Inorg Chem. 2019;24:1197\u2013215.","journal-title":"JBIC J Biol Inorg Chem"},{"key":"504_CR199","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1002\/anie.201006335","volume":"50","author":"JT Pedersen","year":"2011","unstructured":"Pedersen JT, Teilum K, Heegaard NHH, \u00d8stergaard J, Adolph H-W, Hemmingsen L. Rapid formation of a preoligomeric peptide\u2013metal\u2013peptide complex following copper(II) binding to amyloid \u03b2 peptides. Angew Chem Int Ed. 2011;50:2532\u20135.","journal-title":"Angew Chem Int Ed"},{"key":"504_CR200","doi-asserted-by":"publisher","first-page":"10810","DOI":"10.1021\/bi0508237","volume":"44","author":"L Miravalle","year":"2005","unstructured":"Miravalle L, Calero M, Takao M, Roher AE, Ghetti B, Vidal R. Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques. Biochemistry. 2005;44:10810\u201321.","journal-title":"Biochemistry"},{"key":"504_CR201","doi-asserted-by":"publisher","first-page":"9816","DOI":"10.1002\/anie.201704618","volume":"56","author":"JD Barritt","year":"2017","unstructured":"Barritt JD, Younan ND, Viles JH. N-terminally truncated amyloid-\u03b2(11\u201340\/42) cofibrillizes with its full-length counterpart: implications for Alzheimer\u2019s disease. Angew Chem Int Ed Engl. 2017;56:9816\u20139.","journal-title":"Angew Chem Int Ed Engl"},{"key":"504_CR202","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neulet.2011.09.071","volume":"505","author":"CP Sullivan","year":"2011","unstructured":"Sullivan CP, Berg EA, Elliott-Bryant R, Fishman JB, McKee AC, Morin PJ, et al. Pyroglutamate-A\u03b2 3 and 11 colocalize in amyloid plaques in Alzheimer\u2019s disease cerebral cortex with pyroglutamate-A\u03b2 11 forming the central core. Neurosci Lett. 2011;505:109\u201312.","journal-title":"Neurosci Lett"},{"key":"504_CR203","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1039\/c9mt00299e","volume":"12","author":"X Teng","year":"2020","unstructured":"Teng X, Stefaniak E, Girvan P, Kotuniak R, P\u0142onka D, Bal W, et al. Hierarchical binding of copperII to N-truncated A\u03b24-16 peptide. Metallomics. 2020;12:470\u20133.","journal-title":"Metallomics"},{"key":"504_CR204","doi-asserted-by":"publisher","first-page":"10460","DOI":"10.1002\/anie.201502644","volume":"54","author":"M Mital","year":"2015","unstructured":"Mital M, Wezynfeld NE, Fr\u0105czyk T, Wiloch MZ, Wawrzyniak UE, Bonna A, et al. A functional role for A\u03b2 in metal homeostasis? N-truncation and high-affinity copper binding. Angew Chem Int Ed Engl. 2015;54:10460\u20134.","journal-title":"Angew Chem Int Ed Engl"},{"key":"504_CR205","doi-asserted-by":"publisher","first-page":"27791","DOI":"10.1074\/jbc.M115.684084","volume":"290","author":"JD Barritt","year":"2015","unstructured":"Barritt JD, Viles JH. Truncated amyloid-\u03b2(11\u201340\/42) from Alzheimer disease binds Cu2+ with a femtomolar affinity and influences fiber assembly. J Biol Chem. 2015;290:27791\u2013802.","journal-title":"J Biol Chem"},{"key":"504_CR206","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.708119","volume":"15","author":"G Domingo","year":"2021","unstructured":"Domingo G, Benussi L, Saraceno C, Bertuzzi M, Nicsanu R, Longobardi A, et al. N-terminally truncated and pyroglutamate-modified A\u03b2 forms are measurable in human cerebrospinal fluid and are potential markers of disease progression in Alzheimer\u2019s disease. Front Neurosci. 2021;15: 708119.","journal-title":"Front Neurosci"},{"key":"504_CR207","doi-asserted-by":"publisher","first-page":"13561","DOI":"10.1021\/acs.inorgchem.9b01399","volume":"58","author":"E Stefaniak","year":"2019","unstructured":"Stefaniak E, Bal W. CuII binding properties of N-truncated A\u03b2 peptides: in search of biological function. Inorg Chem. 2019;58:13561\u201377.","journal-title":"Inorg Chem"},{"key":"504_CR208","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1039\/B813398K","volume":"7","author":"P Faller","year":"2009","unstructured":"Faller P, Hureau C. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-\u03b2 peptide. Dalton Trans. 2009;7:1080\u201394.","journal-title":"Dalton Trans"},{"key":"504_CR209","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.neurobiolaging.2007.04.013","volume":"29","author":"DP Pelvig","year":"2008","unstructured":"Pelvig DP, Pakkenberg H, Stark AK, Pakkenberg B. Neocortical glial cell numbers in human brains. Neurobiol Aging. 2008;29:1754\u201362.","journal-title":"Neurobiol Aging"},{"key":"504_CR210","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1515\/revneuro-2019-0058","volume":"31","author":"DM Cuestas Torres","year":"2020","unstructured":"Cuestas Torres DM, Cardenas FP. Synaptic plasticity in Alzheimer\u2019s disease and healthy aging. Rev Neurosci. 2020;31:245\u201368.","journal-title":"Rev Neurosci"},{"key":"504_CR211","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1212\/WNL.49.2.610","volume":"49","author":"O Ansorge","year":"1997","unstructured":"Ansorge O, Daniel SE, Pearce RK. Neuronal loss and plasticity in the supraoptic nucleus in Parkinson\u2019s disease. Neurology. 1997;49:610\u20133.","journal-title":"Neurology"},{"key":"504_CR212","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s12035-012-8302-9","volume":"46","author":"F Pilato","year":"2012","unstructured":"Pilato F, Profice P, Ranieri F, Capone F, Di Iorio R, Florio L, et al. Synaptic plasticity in neurodegenerative diseases evaluated and modulated by in vivo neurophysiological techniques. Mol Neurobiol. 2012;46:563\u201371.","journal-title":"Mol Neurobiol"},{"key":"504_CR213","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780195065169.001.0001","volume-title":"Cajals degener regen nerv syst","author":"SRY Cajal","year":"1991","unstructured":"Cajal SRY. Degeneration of Interrupted Nerves. In: Cajal SR, y, DeFelipe J, Jones EG, May RM, editors. Cajal's Degeneration and Regeneration of the Nervous System. Oxford: Oxford University Press; 1991."},{"key":"504_CR214","unstructured":"Hebb DO. The organization of behavior: a neuropsychological theory. Oxford, England: Wiley; 1949. p. xix, 335."},{"key":"504_CR215","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1002\/cne.24040","volume":"524","author":"CS von Bartheld","year":"2016","unstructured":"von Bartheld CS, Bahney J, Herculano-Houzel S. The search for true numbers of neurons and glial cells in the human brain: a review of 150 years of cell counting. J Comp Neurol. 2016;524:3865\u201395.","journal-title":"J Comp Neurol"},{"key":"504_CR216","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1093\/brain\/awt273","volume":"136","author":"CH Andrade-Moraes","year":"2013","unstructured":"Andrade-Moraes CH, Oliveira-Pinto AV, Castro-Fonseca E, da Silva CG, Guimar\u00e3es DM, Szczupak D, et al. Cell number changes in Alzheimer\u2019s disease relate to dementia, not to plaques and tangles. Brain. 2013;136:3738\u201352.","journal-title":"Brain"},{"key":"504_CR217","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z","volume":"379","author":"G Simi\u0107","year":"1997","unstructured":"Simi\u0107 G, Kostovi\u0107 I, Winblad B, Bogdanovi\u0107 N. Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer\u2019s disease. J Comp Neurol. 1997;379:482\u201394.","journal-title":"J Comp Neurol"},{"key":"504_CR218","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.7058341","volume":"215","author":"P Whitehouse","year":"1982","unstructured":"Whitehouse P, Price D, Struble R, Clark A, Coyle J, DeLong MR. Alzheimer\u2019s disease and senile dementia: loss of neurons in the basal forebrain. Science. 1982;215:1237\u20139.","journal-title":"Science"},{"key":"504_CR219","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01466-z","volume":"16","author":"J Lagarde","year":"2024","unstructured":"Lagarde J, Olivieri P, Tonietto M, Noiray C, Lehericy S, Valabr\u00e8gue R, et al. Combined in vivo MRI assessment of locus coeruleus and nucleus basalis of Meynert integrity in amnestic Alzheimer\u2019s disease, suspected-LATE and frontotemporal dementia. Alzheimers Res Ther. 2024;16: 97.","journal-title":"Alzheimers Res Ther"},{"key":"504_CR220","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s43587-024-00626-y","volume":"4","author":"E Bueichek\u00fa","year":"2024","unstructured":"Bueichek\u00fa E, Diez I, Kim C-M, Becker JA, Koops EA, Kwong K, et al. Spatiotemporal patterns of locus coeruleus integrity predict cortical tau and cognition. Nat Aging. 2024;4:625\u201337.","journal-title":"Nat Aging"},{"key":"504_CR221","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00401-011-0871-6","volume":"122","author":"DR Thal","year":"2011","unstructured":"Thal DR, Del Tredici K, Ludolph AC, Hoozemans JJM, Rozemuller AJ, Braak H, et al. Stages of granulovacuolar degeneration: their relation to Alzheimer\u2019s disease and chronic stress response. Acta Neuropathol (Berl). 2011;122:577\u201389.","journal-title":"Acta Neuropathol (Berl)"},{"key":"504_CR222","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01128-y","volume":"14","author":"M Jorge-Oliva","year":"2022","unstructured":"Jorge-Oliva M, Smits JFM, Wiersma VI, Hoozemans JJM, Scheper W. Granulovacuolar degeneration bodies are independently induced by tau and \u03b1-synuclein pathology. Alzheimers Res Ther. 2022;14: 187.","journal-title":"Alzheimers Res Ther"},{"key":"504_CR223","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1039\/C7MT00074J","volume":"9","author":"J Xu","year":"2017","unstructured":"Xu J, Church SJ, Patassini S, Begley P, Waldvogel HJ, Curtis MA, et al. Evidence for widespread, severe brain copper deficiency in Alzheimer\u2019s dementia\u2020. Metallomics. 2017;9:1106\u201319.","journal-title":"Metallomics"},{"key":"504_CR224","doi-asserted-by":"publisher","DOI":"10.1186\/2047-9158-3-24","volume":"3","author":"K Voss","year":"2014","unstructured":"Voss K, Harris C, Ralle M, Duffy M, Murchison C, Quinn JF. Modulation of tau phosphorylation by environmental copper. Transl Neurodegener. 2014;3: 24.","journal-title":"Transl Neurodegener"},{"key":"504_CR225","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","volume":"63","author":"RH Swerdlow","year":"2004","unstructured":"Swerdlow RH, Khan SM. A \u201cmitochondrial cascade hypothesis\u201d for sporadic Alzheimer\u2019s disease. Med Hypotheses. 2004;63:8\u201320.","journal-title":"Med Hypotheses"},{"key":"504_CR226","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1195010","author":"K Seb\u0151k-Nagy","year":"2023","unstructured":"Seb\u0151k-Nagy K, Blasty\u00e1k A, Juh\u00e1sz G, P\u00e1li T. Reversible binding of divalent cations to Ductin protein assemblies\u2014a putative new regulatory mechanism of membrane traffic processes. Front Mol Biosci. 2023. https:\/\/doi.org\/10.3389\/fmolb.2023.1195010.","journal-title":"Front Mol Biosci"},{"key":"504_CR227","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1083\/jcb.201303104","volume":"203","author":"S Po\u00eba-Guyon","year":"2013","unstructured":"Po\u00eba-Guyon S, Ammar MR, Erard M, Amar M, Moreau AW, Fossier P, et al. The V-ATPase membrane domain is a sensor of granular pH that controls the exocytotic machinery. J Cell Biol. 2013;203:283\u201398.","journal-title":"J Cell Biol"},{"key":"504_CR228","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3233\/JAD-2012-120532","volume":"31","author":"G Koch","year":"2012","unstructured":"Koch G, Di Lorenzo F, Bonn\u00ec S, Ponzo V, Caltagirone C, Martorana A. Impaired LTP- but not LTD-like cortical plasticity in Alzheimer\u2019s disease patients. J Alzheimers Dis JAD. 2012;31:593\u20139.","journal-title":"J Alzheimers Dis JAD"},{"key":"504_CR229","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416:535\u20139.","journal-title":"Nature"},{"key":"504_CR230","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1523\/JNEUROSCI.2774-16.2016","volume":"37","author":"GA Prieto","year":"2017","unstructured":"Prieto GA, Trieu BH, Dang CT, Bilousova T, Gylys KH, Berchtold NC, et al. Pharmacological rescue of long-term potentiation in Alzheimer diseased synapses. J Neurosci. 2017;37:1197\u2013212.","journal-title":"J Neurosci"},{"key":"504_CR231","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nchembio.89","volume":"4","author":"G Meloni","year":"2008","unstructured":"Meloni G, Sonois V, Delaine T, Guilloreau L, Gillet A, Teissi\u00e9 J, et al. Metal swap between Zn7-metallothionein-3 and amyloid-beta-Cu protects against amyloid-beta toxicity. Nat Chem Biol. 2008;4:366\u201372.","journal-title":"Nat Chem Biol"},{"key":"504_CR232","doi-asserted-by":"publisher","first-page":"11634","DOI":"10.1039\/C7CC06802F","volume":"53","author":"A Santoro","year":"2017","unstructured":"Santoro A, Ewa Wezynfeld N, Va\u0161\u00e1k M, Bal W, Faller P. Cysteine and glutathione trigger the Cu\u2013Zn swap between Cu(ii)-amyloid-\u03b24-16 peptide and Zn7-metallothionein-3. Chem Commun Camb Engl. 2017;53:11634\u20137.","journal-title":"Chem Commun Camb Engl"},{"key":"504_CR233","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.biopsych.2015.04.005","volume":"78","author":"PK Mandal","year":"2015","unstructured":"Mandal PK, Saharan S, Tripathi M, Murari G. Brain glutathione levels \u2013 a novel biomarker for mild cognitive impairment and Alzheimer\u2019s disease. Biol Psychiatry. 2015;78:702\u201310.","journal-title":"Biol Psychiatry"},{"key":"504_CR234","doi-asserted-by":"publisher","first-page":"10831","DOI":"10.1021\/bi001048s","volume":"39","author":"DM Walsh","year":"2000","unstructured":"Walsh DM, Tseng BP, Rydel RE, Podlisny MB, Selkoe DJ. The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry. 2000;39:10831\u20139.","journal-title":"Biochemistry"},{"key":"504_CR235","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1073\/pnas.96.2.742","volume":"96","author":"JP Greenfield","year":"1999","unstructured":"Greenfield JP, Tsai J, Gouras GK, Hai B, Thinakaran G, Checler F, et al. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc Natl Acad Sci U S A. 1999;96:742\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"504_CR236","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/nm0997-1016","volume":"3","author":"T Hartmann","year":"1997","unstructured":"Hartmann T, Bieger SC, Br\u00fchl B, Tienari PJ, Ida N, Allsop D, et al. Distinct sites of intracellular production for Alzheimer\u2019s disease A beta40\/42 amyloid peptides. Nat Med. 1997;3:1016\u201320.","journal-title":"Nat Med"},{"key":"504_CR237","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0002-9440(10)64700-1","volume":"156","author":"GK Gouras","year":"2000","unstructured":"Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, et al. Intraneuronal A\u03b242 accumulation in human brain. Am J Pathol. 2000;156:15\u201320.","journal-title":"Am J Pathol"},{"key":"504_CR238","doi-asserted-by":"publisher","first-page":"17930","DOI":"10.1074\/jbc.M412034200","volume":"280","author":"B Angeletti","year":"2005","unstructured":"Angeletti B, Waldron KJ, Freeman KB, Bawagan H, Hussain I, Miller CCJ, et al. BACE1 cytoplasmic domain interacts with the copper chaperone for superoxide dismutase-1 and binds copper. J Biol Chem. 2005;280:17930\u20137.","journal-title":"J Biol Chem"},{"key":"504_CR239","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1111\/j.1471-4159.2009.05901.x","volume":"108","author":"M Kitazawa","year":"2009","unstructured":"Kitazawa M, Cheng D, Laferla FM. Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD. J Neurochem. 2009;108:1550\u201360.","journal-title":"J Neurochem"},{"key":"504_CR240","doi-asserted-by":"publisher","first-page":"11007","DOI":"10.1074\/jbc.M113.538710","volume":"289","author":"KM Acevedo","year":"2014","unstructured":"Acevedo KM, Opazo CM, Norrish D, Challis LM, Li Q-X, White AR, et al. Phosphorylation of amyloid precursor protein at threonine 668 is essential for its copper-responsive trafficking in SH-SY5Y neuroblastoma cells. J Biol Chem. 2014;289:11007\u201319.","journal-title":"J Biol Chem"},{"key":"504_CR241","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1073\/pnas.0809057106","volume":"106","author":"PJ Crouch","year":"2009","unstructured":"Crouch PJ, Hung LW, Adlard PA, Cortes M, Lal V, Filiz G, et al. Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation. Proc Natl Acad Sci U S A. 2009;106:381\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"504_CR242","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1471-4159.2004.02737.x","volume":"91","author":"O Wirths","year":"2004","unstructured":"Wirths O, Multhaup G, Bayer TA. A modified \u03b2-amyloid hypothesis: intraneuronal accumulation of the \u03b2-amyloid peptide \u2013 the first step of a fatal cascade. J Neurochem. 2004;91:513\u201320.","journal-title":"J Neurochem"},{"key":"504_CR243","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner LM, G\u00f6tz J. Amyloid-\u03b2 and tau \u2014 a toxic pas de deux in Alzheimer\u2019s disease. Nat Rev Neurosci. 2011;12:67\u201372.","journal-title":"Nat Rev Neurosci"},{"key":"504_CR244","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neuint.2008.10.013","volume":"54","author":"H Lee","year":"2009","unstructured":"Lee H, Casadesus G, Zhu X, Castellani RJ, McShea A, Perry G, et al. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer\u2019s disease. Neurochem Int. 2009;54:84\u20138.","journal-title":"Neurochem Int"},{"key":"504_CR245","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12640-011-9277-4","volume":"22","author":"J Folch","year":"2012","unstructured":"Folch J, Junyent F, Verdaguer E, Auladell C, Pizarro JG, Beas-Zarate C, et al. Role of cell cycle re-entry in neurons: a common apoptotic mechanism of neuronal cell death. Neurotox Res. 2012;22:195\u2013207.","journal-title":"Neurotox Res"},{"key":"504_CR246","doi-asserted-by":"publisher","first-page":"26377","DOI":"10.1074\/jbc.M110.145516","volume":"285","author":"S Chen","year":"2010","unstructured":"Chen S, Yadav SP, Surewicz WK. Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues. J Biol Chem. 2010;285:26377\u201383.","journal-title":"J Biol Chem"},{"key":"504_CR247","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nature07761","volume":"457","author":"J Laur\u00e9n","year":"2009","unstructured":"Laur\u00e9n J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature. 2009;457:1128\u201332.","journal-title":"Nature"},{"key":"504_CR248","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2014.00045","volume":"2","author":"SAG Black","year":"2014","unstructured":"Black SAG, Stys PK, Zamponi GW, Tsutsui S. Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity. Front Cell Dev Biol. 2014;2: 45.","journal-title":"Front Cell Dev Biol"},{"key":"504_CR249","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1089\/ars.2014.6032","volume":"22","author":"L Gasperini","year":"2015","unstructured":"Gasperini L, Meneghetti E, Pastore B, Benetti F, Legname G. Prion protein and copper cooperatively protect neurons by modulating NMDA receptor through S-nitrosylation. Antioxid Redox Signal. 2015;22:772\u201384.","journal-title":"Antioxid Redox Signal"},{"key":"504_CR250","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1523\/JNEUROSCI.3699-04.2005","volume":"25","author":"ML Schlief","year":"2005","unstructured":"Schlief ML, Craig AM, Gitlin JD. NMDA receptor activation mediates copper homeostasis in hippocampal neurons. J Neurosci. 2005;25:239\u201346.","journal-title":"J Neurosci"},{"key":"504_CR251","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/JAD-2009-0933","volume":"16","author":"P Hernandez","year":"2009","unstructured":"Hernandez P, Lee G, Sjoberg M, Maccioni RB. Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Abeta (25\u201335): involvement of lipid rafts. J Alzheimers Dis. 2009;16:149\u201356.","journal-title":"J Alzheimers Dis JAD"},{"key":"504_CR252","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/sj.emboj.7600441","volume":"24","author":"Y-L Zheng","year":"2005","unstructured":"Zheng Y-L, Kesavapany S, Gravell M, Hamilton RS, Schubert M, Amin N, et al. A cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J. 2005;24:209\u201320.","journal-title":"EMBO J"},{"key":"504_CR253","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1113\/jphysiol.2001.013258","volume":"539","author":"EN Dedkova","year":"2002","unstructured":"Dedkova EN, Blatter LA. Nitric oxide inhibits capacitative Ca2+ entry and enhances endoplasmic reticulum Ca2+ uptake in bovine vascular endothelial cells. J Physiol. 2002;539:77\u201391.","journal-title":"J Physiol"},{"key":"504_CR254","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2174\/1566524019666191129103117","volume":"20","author":"H Dubey","year":"2020","unstructured":"Dubey H, Gulati K, Ray A. Alzheimer\u2019s disease: a contextual link with nitric oxide synthase. Curr Mol Med. 2020;20:505\u201315.","journal-title":"Curr Mol Med"},{"key":"504_CR255","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0006-8993(01)02758-5","volume":"913","author":"HJ L\u00fcth","year":"2001","unstructured":"L\u00fcth HJ, Holzer M, G\u00e4rtner U, Staufenbiel M, Arendt T. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer\u2019s disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology. Brain Res. 2001;913:57\u201367.","journal-title":"Brain Res"},{"key":"504_CR256","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/bpa.12401","volume":"26","author":"S Love","year":"2016","unstructured":"Love S, Miners JS. Cerebral hypoperfusion and the energy deficit in Alzheimer\u2019s disease. Brain Pathol. 2016;26:607\u201317.","journal-title":"Brain Pathol"},{"key":"504_CR257","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.cveq.2008.05.003","volume":"24","author":"JB Carrick","year":"2008","unstructured":"Carrick JB, Begg AP. Peripheral blood leukocytes. Vet Clin North Am Equine Pract. 2008;24:239\u201359.","journal-title":"Vet Clin North Am Equine Pract"},{"key":"504_CR258","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev-immunol-032713-120240","volume":"32","author":"D Nayak","year":"2014","unstructured":"Nayak D, Roth TL, McGavern DB. Microglia development and function. Annu Rev Immunol. 2014;32:367\u2013402.","journal-title":"Annu Rev Immunol"},{"key":"504_CR259","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1194637","volume":"330","author":"F Ginhoux","year":"2010","unstructured":"Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330:841\u20135.","journal-title":"Science"},{"key":"504_CR260","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.biocel.2017.11.012","volume":"94","author":"L Sominsky","year":"2018","unstructured":"Sominsky L, De Luca S, Spencer SJ. Microglia: key players in neurodevelopment and neuronal plasticity. Int J Biochem Cell Biol. 2018;94:56\u201360.","journal-title":"Int J Biochem Cell Biol"},{"key":"504_CR261","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1202529","volume":"333","author":"RC Paolicelli","year":"2011","unstructured":"Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333:1456\u20138.","journal-title":"Science"},{"key":"504_CR262","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.1110647","volume":"308","author":"A Nimmerjahn","year":"2005","unstructured":"Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308:1314\u20138.","journal-title":"Science"},{"key":"504_CR263","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","volume":"173","author":"R Orihuela","year":"2016","unstructured":"Orihuela R, McPherson CA, Harry GJ. Microglial M1\/M2 polarization and metabolic states. Br J Pharmacol. 2016;173:649\u201365.","journal-title":"Br J Pharmacol"},{"issue":"169","key":"504_CR264","first-page":"2253","volume":"2002","author":"R Lang","year":"1950","unstructured":"Lang R, Patel D, Morris JJ, Rutschman RL, Murray PJ. Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol Baltim Md. 1950;2002(169):2253\u201363.","journal-title":"J Immunol Baltim Md"},{"key":"504_CR265","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","volume":"27","author":"FO Martinez","year":"2009","unstructured":"Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2009;27:451\u201383.","journal-title":"Annu Rev Immunol"},{"key":"504_CR266","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nn.4338","volume":"19","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19:987\u201391.","journal-title":"Nat Neurosci"},{"key":"504_CR267","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","volume":"173","author":"A Deczkowska","year":"2018","unstructured":"Deczkowska A, Keren-Shaul H, Weiner A, Colonna M, Schwartz M, Amit I. Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell. 2018;173:1073\u201381.","journal-title":"Cell"},{"key":"504_CR268","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0254-8","volume":"13","author":"S Rangaraju","year":"2018","unstructured":"Rangaraju S, Dammer EB, Raza SA, Rathakrishnan P, Xiao H, Gao T, et al. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u2019s disease. Mol Neurodegener. 2018;13: 24.","journal-title":"Mol Neurodegener"},{"key":"504_CR269","first-page":"792","volume":"140","author":"Z Fan","year":"2017","unstructured":"Fan Z, Brooks DJ, Okello A, Edison P. An early and late peak in microglial activation in Alzheimer\u2019s disease trajectory. Brain J Neurol. 2017;140:792\u2013803.","journal-title":"Brain J Neurol"},{"key":"504_CR270","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","volume":"18","author":"Y Shi","year":"2018","unstructured":"Shi Y, Holtzman DM. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat Rev Immunol. 2018;18:759\u201372.","journal-title":"Nat Rev Immunol"},{"key":"504_CR271","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1111\/j.1471-4159.2010.06888.x","volume":"114","author":"Z Zheng","year":"2010","unstructured":"Zheng Z, White C, Lee J, Peterson TS, Bush AI, Sun G, et al. Altered microglial copper homeostasis in a mouse model of Alzheimer\u2019s diseasE. J Neurochem. 2010;114:1630\u20138.","journal-title":"J Neurochem"},{"key":"504_CR272","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/374647a0","volume":"374","author":"L Meda","year":"1995","unstructured":"Meda L, Cassatella MA, Szendrei GI, Otvos L, Baron P, Villalba M, et al. Activation of microglial cells by \u03b2-amyloid protein and interferon-\u03b3. Nature. 1995;374:647\u201350.","journal-title":"Nature"},{"key":"504_CR273","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1089\/jir.2013.0085","volume":"34","author":"M Belkhelfa","year":"2014","unstructured":"Belkhelfa M, Rafa H, Medjeber O, Arroul-Lammali A, Behairi N, Abada-Bendib M, et al. IFN-\u03b3 and TNF-\u03b1 are involved during Alzheimer disease progression and correlate with nitric oxide production: a study in Algerian patients.\u00a0J Interferon Cytokine Res. 2014;34:839\u201347.","journal-title":"J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res"},{"key":"504_CR274","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.taap.2014.01.020","volume":"276","author":"Z Hu","year":"2014","unstructured":"Hu Z, Yu F, Gong P, Qiu Y, Zhou W, Cui Y, et al. Subneurotoxic copper(II)-induced NF-\u03baB-dependent microglial activation is associated with mitochondrial ROS. Toxicol Appl Pharmacol. 2014;276:95\u2013103.","journal-title":"Toxicol Appl Pharmacol"},{"key":"504_CR275","first-page":"4854","volume":"62","author":"Q Pan","year":"2002","unstructured":"Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C, et al. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res. 2002;62:4854\u20139.","journal-title":"Cancer Res"},{"key":"504_CR276","doi-asserted-by":"publisher","first-page":"6700","DOI":"10.1073\/pnas.1231994100","volume":"100","author":"L Mandinov","year":"2003","unstructured":"Mandinov L, Mandinova A, Kyurkchiev S, Kyurkchiev D, Kehayov I, Kolev V, et al. Copper chelation represses the vascular response to injury. Proc Natl Acad Sci U S A. 2003;100:6700\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"504_CR277","doi-asserted-by":"publisher","first-page":"14919","DOI":"10.1073\/pnas.0605390103","volume":"103","author":"ML Schlief","year":"2006","unstructured":"Schlief ML, West T, Craig AM, Holtzman DM, Gitlin JD. Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity. Proc Natl Acad Sci. 2006;103:14919\u201324.","journal-title":"Proc Natl Acad Sci"},{"key":"504_CR278","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/inorganics10010006","volume":"10","author":"S Bagheri","year":"2022","unstructured":"Bagheri S, Saboury AA, Haertl\u00e9 T, Rongioletti M, Saso L. Probable reasons for neuron copper deficiency in the brain of patients with Alzheimer\u2019s disease: the complex role of amyloid. Inorganics. 2022;10:6.","journal-title":"Inorganics"},{"key":"504_CR279","doi-asserted-by":"publisher","first-page":"C768","DOI":"10.1152\/ajpcell.00417.2012","volume":"304","author":"EB Maryon","year":"2013","unstructured":"Maryon EB, Molloy SA, Kaplan JH. Cellular glutathione plays a key role in copper uptake mediated by human copper transporter 1. Am J Physiol Cell Physiol. 2013;304:C768\u201379.","journal-title":"Am J Physiol Cell Physiol"},{"key":"504_CR280","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.834697","author":"GC Brown","year":"2022","unstructured":"Brown GC, St George-Hyslop P. Does soluble TREM2 protect against Alzheimer\u2019s disease? Front Aging Neurosci. 2022. https:\/\/doi.org\/10.3389\/fnagi.2021.834697.","journal-title":"Front Aging Neurosci"},{"key":"504_CR281","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-03397-1","volume":"12","author":"J Dong","year":"2021","unstructured":"Dong J, Wang X, Xu C, Gao M, Wang S, Zhang J, et al. Inhibiting NLRP3 inflammasome activation prevents copper-induced neuropathology in a murine model of Wilson\u2019s disease. Cell Death Dis. 2021;12:1\u201312.","journal-title":"Cell Death Dis"},{"key":"504_CR282","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.845185","volume":"13","author":"T Liang","year":"2022","unstructured":"Liang T, Zhang Y, Wu S, Chen Q, Wang L. The role of NLRP3 inflammasome in Alzheimer\u2019s disease and potential therapeutic targets. Front Pharmacol. 2022;13: 845185.","journal-title":"Front Pharmacol"},{"key":"504_CR283","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","volume":"552","author":"C Venegas","year":"2017","unstructured":"Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, et al. Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease. Nature. 2017;552:355\u201361.","journal-title":"Nature"},{"key":"504_CR284","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00076","volume":"9","author":"C Schitine","year":"2015","unstructured":"Schitine C, Nogaroli L, Costa MR, Hedin-Pereira C. Astrocyte heterogeneity in the brain: from development to disease. Front Cell Neurosci. 2015;9: 76.","journal-title":"Front Cell Neurosci"},{"key":"504_CR285","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00429-017-1383-5","volume":"222","author":"F Vasile","year":"2017","unstructured":"Vasile F, Dossi E, Rouach N. Human astrocytes: structure and functions in the healthy brain. Brain Struct Funct. 2017;222:2017\u201329.","journal-title":"Brain Struct Funct"},{"key":"504_CR286","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1152\/physrev.00042.2016","volume":"98","author":"A Verkhratsky","year":"2018","unstructured":"Verkhratsky A, Nedergaard M. Physiology of astroglia. Physiol Rev. 2018;98:239\u2013389.","journal-title":"Physiol Rev"},{"key":"504_CR287","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/glia.23736","volume":"68","author":"T Cl\u00e9ment","year":"2020","unstructured":"Cl\u00e9ment T, Lee JB, Ichkova A, Rodriguez-Grande B, Fournier M-L, Aussudre J, et al. Juvenile mild traumatic brain injury elicits distinct spatiotemporal astrocyte responses. Glia. 2020;68:528\u201342.","journal-title":"Glia"},{"key":"504_CR288","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cells8020184","volume":"8","author":"S Mahmoud","year":"2019","unstructured":"Mahmoud S, Gharagozloo M, Simard C, Gris D. Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release. Cells. 2019;8:184.","journal-title":"Cells"},{"key":"504_CR289","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.03913.x","volume":"98","author":"LK Bak","year":"2006","unstructured":"Bak LK, Schousboe A, Waagepetersen HS. The glutamate\/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem. 2006;98:641\u201353.","journal-title":"J Neurochem"},{"key":"504_CR290","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a020370","volume":"7","author":"W-S Chung","year":"2015","unstructured":"Chung W-S, Allen NJ, Eroglu C. Astrocytes control synapse formation, function, and elimination. Cold Spring Harb Perspect Biol. 2015;7: a020370.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"504_CR291","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41586-020-03060-3","volume":"590","author":"J-H Lee","year":"2021","unstructured":"Lee J-H, Kim J, Noh S, Lee H, Lee SY, Mun JY, et al. Astrocytes phagocytose adult hippocampal synapses for circuit homeostasis. Nature. 2021;590:612\u20137.","journal-title":"Nature"},{"key":"504_CR292","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nn.4201","volume":"19","author":"N Bazargani","year":"2016","unstructured":"Bazargani N, Attwell D. Astrocyte calcium signaling: the third wave. Nat Neurosci. 2016;19:182\u20139.","journal-title":"Nat Neurosci"},{"key":"504_CR293","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/nan.12338","volume":"43","author":"CJ Garwood","year":"2017","unstructured":"Garwood CJ, Ratcliffe LE, Simpson JE, Heath PR, Ince PG, Wharton SB. Astrocytes in Alzheimer\u2019s disease and other age-associated dementias: a supporting player with a central role. Neuropathol Appl Neurobiol. 2017;43:281\u201398.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"504_CR294","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1523\/JNEUROSCI.22-01-00183.2002","volume":"22","author":"EA Bushong","year":"2002","unstructured":"Bushong EA, Martone ME, Jones YZ, Ellisman MH. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci. 2002;22:183\u201392.","journal-title":"J Neurosci"},{"key":"504_CR295","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1523\/JNEUROSCI.4707-08.2009","volume":"29","author":"NA Oberheim","year":"2009","unstructured":"Oberheim NA, Takano T, Han X, He W, Lin JHC, Wang F, et al. Uniquely hominid features of adult human astrocytes. J Neurosci. 2009;29:3276\u201387.","journal-title":"J Neurosci"},{"key":"504_CR296","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/glia.20967","volume":"58","author":"M Olabarria","year":"2010","unstructured":"Olabarria M, Noristani HN, Verkhratsky A, Rodr\u00edguez JJ. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer\u2019s disease. Glia. 2010;58:831\u20138.","journal-title":"Glia"},{"key":"504_CR297","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02752-7","volume":"20","author":"M-K St-Pierre","year":"2023","unstructured":"St-Pierre M-K, Carrier M, Gonz\u00e1lez Ib\u00e1\u00f1ez F, Khakpour M, Wallman M-J, Parent M, et al. Astrocytes display ultrastructural alterations and heterogeneity in the hippocampus of aged APP-PS1 mice and human post-mortem brain samples. J Neuroinflammation. 2023;20: 73.","journal-title":"J Neuroinflammation"},{"key":"504_CR298","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0891-5849(97)00120-2","volume":"23","author":"TE Morgan","year":"1997","unstructured":"Morgan TE, Rozovsky I, Goldsmith SK, Stone DJ, Yoshida T, Finch CE. Increased transcription of the astrocyte gene GFAP during middle-age is attenuated by food restriction: implications for the role of oxidative stress. Free Radic Biol Med. 1997;23:524\u20138.","journal-title":"Free Radic Biol Med"},{"key":"504_CR299","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137.","journal-title":"Nature"},{"key":"504_CR300","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/jnr.20864","volume":"84","author":"S Bandyopadhyay","year":"2006","unstructured":"Bandyopadhyay S, Hartley DM, Cahill CM, Lahiri DK, Chattopadhyay N, Rogers JT. Interleukin-1alpha stimulates non-amyloidogenic pathway by alpha-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase. J Neurosci Res. 2006;84:106\u201318.","journal-title":"J Neurosci Res"},{"key":"504_CR301","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(18)30490-3","volume":"18","author":"AM Arranz","year":"2019","unstructured":"Arranz AM, De Strooper B. The role of astroglia in Alzheimer\u2019s disease: pathophysiology and clinical implications. Lancet Neurol. 2019;18:406\u201314.","journal-title":"Lancet Neurol"},{"key":"504_CR302","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1523\/JNEUROSCI.3442-16.2017","volume":"37","author":"C-C Liu","year":"2017","unstructured":"Liu C-C, Hu J, Zhao N, Wang J, Wang N, Cirrito JR, et al. Astrocytic LRP1 mediates brain A\u03b2 clearance and impacts amyloid deposition. J Neurosci. 2017;37:4023\u201331.","journal-title":"J Neurosci"},{"key":"504_CR303","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155878","volume":"11","author":"L Auderset","year":"2016","unstructured":"Auderset L, Cullen CL, Young KM. Low density lipoprotein-receptor related protein 1 is differentially expressed by neuronal and glial populations in the developing and mature mouse central nervous system. PLoS One. 2016;11: e0155878.","journal-title":"PLoS ONE"},{"key":"504_CR304","doi-asserted-by":"publisher","first-page":"14771","DOI":"10.1073\/pnas.1302212110","volume":"110","author":"I Singh","year":"2013","unstructured":"Singh I, Sagare AP, Coma M, Perlmutter D, Gelein R, Bell RD, et al. Low levels of copper disrupt brain amyloid-\u03b2 homeostasis by altering its production and clearance. Proc Natl Acad Sci U S A. 2013;110:14771\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"504_CR305","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","volume":"85","author":"H Lian","year":"2015","unstructured":"Lian H, Yang L, Cole A, Sun L, Chiang AC-A, Fowler SW, et al. NF\u03bab-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer\u2019s disease. Neuron. 2015;85:101\u201315.","journal-title":"Neuron"},{"key":"504_CR306","doi-asserted-by":"publisher","first-page":"10016","DOI":"10.1073\/pnas.89.21.10016","volume":"89","author":"J Rogers","year":"1992","unstructured":"Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD, et al. Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci U S A. 1992;89:10016\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"504_CR307","doi-asserted-by":"publisher","first-page":"423.e1","DOI":"10.1016\/j.neurobiolaging.2010.09.018","volume":"33","author":"ML Steele","year":"2012","unstructured":"Steele ML, Robinson SR. Reactive astrocytes give neurons less support: implications for Alzheimer\u2019s disease. Neurobiol Aging. 2012;33:423.e1-423.e13.","journal-title":"Neurobiol Aging"},{"key":"504_CR308","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.neuint.2012.08.017","volume":"62","author":"IF Scheiber","year":"2013","unstructured":"Scheiber IF, Dringen R. Astrocyte functions in the copper homeostasis of the brain. Neurochem Int. 2013;62:556\u201365.","journal-title":"Neurochem Int"},{"key":"504_CR309","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jinorgbio.2012.08.021","volume":"117","author":"A Rocchi","year":"2012","unstructured":"Rocchi A, Valensin D, Aldinucci C, Giani G, Barbucci R, Gaggelli E, et al. NMR metabolomic investigation of astrocytes interacted with A\u03b242 or its complexes with either copper(II) or zinc(II). J Inorg Biochem. 2012;117:326\u201333.","journal-title":"J Inorg Biochem"},{"key":"504_CR310","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.2174\/092986709787846622","volume":"16","author":"H Xie","year":"2009","unstructured":"Xie H, Kang YJ. Role of copper in angiogenesis and its medicinal implications. Curr Med Chem. 2009;16:1304\u201314.","journal-title":"Curr Med Chem"},{"key":"504_CR311","first-page":"1138","volume":"18","author":"Y Huang","year":"2004","unstructured":"Huang Y, Hickey RP, Yeh JL, Liu D, Dadak A, Young LH, et al. Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. FASEB J. 2004;18:1138\u201340.","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"504_CR312","doi-asserted-by":"publisher","first-page":"17385","DOI":"10.1073\/pnas.1003996107","volume":"107","author":"RE Haskew-Layton","year":"2010","unstructured":"Haskew-Layton RE, Payappilly JB, Smirnova NA, Ma TC, Chan KK, Murphy TH, et al. Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway. Proc Natl Acad Sci U S A. 2010;107:17385\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"504_CR313","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3233\/JAD-170662","volume":"62","author":"PA Adlard","year":"2018","unstructured":"Adlard PA, Bush AI. Metals and Alzheimer\u2019s disease: how far have we come in the clinic? J Alzheimers Dis. 2018;62:1369\u201379.","journal-title":"J Alzheimers Dis"},{"issue":"115","key":"504_CR314","first-page":"1181","volume":"2008","author":"H Kessler","year":"1996","unstructured":"Kessler H, Bayer TA, Bach D, Schneider-Axmann T, Supprian T, Herrmann W, et al. Intake of copper has no effect on cognition in patients with mild Alzheimer\u2019s disease: a pilot phase 2 clinical trial. J Neural Transm Vienna Austria. 1996;2008(115):1181\u20137.","journal-title":"J Neural Transm Vienna Austria"},{"key":"504_CR315","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1046\/j.1365-2362.2002.00933.x","volume":"32","author":"R Squitti","year":"2002","unstructured":"Squitti R, Rossini PM, Cassetta E, Moffa F, Pasqualetti P, Cortesi M, et al. D-penicillamine reduces serum oxidative stress in Alzheimer\u2019s disease patients. Eur J Clin Invest. 2002;32:51\u20139.","journal-title":"Eur J Clin Invest"},{"key":"504_CR316","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0210-5705(03)70465-8","volume":"27","author":"B Serra","year":"2004","unstructured":"Serra B, Primo J, Garc\u00eda M, Amor\u00f3s I, Arag\u00f3 M. Merino C. Wilson\u2019s disease with severe neurological manifestations: response to trientine plus zinc therapy. Gastroenterol Hepatol. 2004;27:307\u201310.","journal-title":"Gastroenterol Hepatol"},{"key":"504_CR317","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","volume":"337","author":"DRC McLachlan","year":"1991","unstructured":"McLachlan DRC, Kruck TPA, Kalow W, Andrews DF, Dalton AJ, Bell MY, et al. Intramuscular desferrioxamine in patients with Alzheimer\u2019s disease. The Lancet. 1991;337:1304\u20138.","journal-title":"The Lancet"},{"issue":"9","key":"504_CR318","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","volume":"7","author":"L Lannfelt","year":"2008","unstructured":"Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J, et al. Safety, efficacy, and biomarker findings of PBT2 in targeting A\u03b2 as a modifying therapy for Alzheimer\u2019s disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2008;7(9):779\u201386.","journal-title":"Lancet Neurol"},{"key":"504_CR319","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","volume":"60","author":"CW Ritchie","year":"2003","unstructured":"Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol. 2003;60:1685\u201391.","journal-title":"Arch Neurol"},{"key":"504_CR320","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.trci.2017.10.001","volume":"3","author":"VL Villemagne","year":"2017","unstructured":"Villemagne VL, Rowe CC, Barnham KJ, Cherny R, Woodward M, Bozinosvski S, et al. A randomized, exploratory molecular imaging study targeting amyloid \u03b2 with a novel 8-OH quinoline in Alzheimer\u2019s disease: the PBT2-204 IMAGINE study. Alzheimers Dement. 2017;3:622\u201335.","journal-title":"Alzheimers Dement N Y N"},{"key":"504_CR321","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254\u201361.","journal-title":"Science"},{"key":"504_CR322","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","volume":"30","author":"RA Cherny","year":"2001","unstructured":"Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits \u03b2-amyloid accumulation in Alzheimer\u2019s disease transgenic mice. Neuron. 2001;30:665\u201376.","journal-title":"Neuron"},{"key":"504_CR323","doi-asserted-by":"publisher","first-page":"17670","DOI":"10.1074\/jbc.M602487200","volume":"281","author":"AR White","year":"2006","unstructured":"White AR, Du T, Laughton KM, Volitakis I, Sharples RA, Xilinas ME, et al. Degradation of the Alzheimer disease amyloid \u03b2-peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem. 2006;281:17670\u201380.","journal-title":"J Biol Chem"},{"key":"504_CR324","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1432-1033.1980.tb06059.x","volume":"107","author":"N Embi","year":"1980","unstructured":"Embi N, Rylatt DB, Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Eur J Biochem. 1980;107:519\u201327.","journal-title":"Eur J Biochem"},{"key":"504_CR325","doi-asserted-by":"publisher","first-page":"11074","DOI":"10.1073\/pnas.190297597","volume":"97","author":"RV Bhat","year":"2000","unstructured":"Bhat RV, Shanley J, Correll MP, Fieles WE, Keith RA, Scott CW, et al. Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc Natl Acad Sci U S A. 2000;97:11074\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"504_CR326","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0014-5793(97)00490-0","volume":"410","author":"P Cohen","year":"1997","unstructured":"Cohen P, Alessi DR, Cross DA. PDK1, one of the missing links in insulin signal transduction? FEBS Lett. 1997;410:3\u201310.","journal-title":"FEBS Lett"},{"key":"504_CR327","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0014-5793(00)01234-5","volume":"469","author":"I Tsujio","year":"2000","unstructured":"Tsujio I, Tanaka T, Kudo T, Nishikawa T, Shinozaki K, Grundke-Iqbal I, et al. Inactivation of glycogen synthase kinase-3 by protein kinase C \u03b4: implications for regulation of \u03c4 phosphorylation. FEBS Lett. 2000;469:111\u20137.","journal-title":"FEBS Lett"},{"key":"504_CR328","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/bj3030021","volume":"303","author":"DAE Cross","year":"1994","unstructured":"Cross DAE, Alessi DR, Vandenheede JR, McDowell HE, Hundal HS, Cohen P. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J. 1994;303:21\u20136.","journal-title":"Biochem J"},{"key":"504_CR329","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118664","volume":"1867","author":"E Lauretti","year":"2020","unstructured":"Lauretti E, Dincer O, Pratic\u00f2 D. Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease. Biochim Biophys Acta. 2020;1867: 118664.","journal-title":"Biochim Biophys Acta BBA Mol Cell Res"},{"key":"504_CR330","doi-asserted-by":"publisher","first-page":"16502","DOI":"10.1074\/jbc.M611336200","volume":"282","author":"AK Jain","year":"2007","unstructured":"Jain AK, Jaiswal AK. GSK-3\u03b2 acts upstream of fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem. 2007;282:16502\u201310.","journal-title":"J Biol Chem"},{"key":"504_CR331","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/00001756-199304000-00024","volume":"4","author":"SK Shirazi","year":"1993","unstructured":"Shirazi SK, Wood JG. The protein tyrosine kinase, fyn, in Alzheimer\u2019s disease pathology. NeuroReport. 1993;4:435\u20137.","journal-title":"NeuroReport"},{"key":"504_CR332","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1523\/JNEUROSCI.4162-03.2004","volume":"24","author":"G Lee","year":"2004","unstructured":"Lee G, Thangavel R, Sharma VM, Litersky JM, Bhaskar K, Fang SM, et al. Phosphorylation of tau by fyn: implications for Alzheimer\u2019s disease. J Neurosci. 2004;24:2304\u201312.","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"504_CR333","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1006\/bbrc.1995.2662","volume":"216","author":"T Suzuki","year":"1995","unstructured":"Suzuki T, Okumura-Noji K. NMDA receptor subunits epsilon 1 (NR2A) and epsilon 2 (NR2B) are substrates for Fyn in the postsynaptic density fraction isolated from the rat brain. Biochem Biophys Res Commun. 1995;216:582\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"504_CR334","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s13273-013-0009-0","volume":"9","author":"D-K Kim","year":"2013","unstructured":"Kim D-K, Song J-W, Park J-D, Choi B-S. Copper induces the accumulation of amyloid-beta in the brain. Mol Cell Toxicol. 2013;9:57\u201366.","journal-title":"Mol Cell Toxicol"},{"key":"504_CR335","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022113246","volume":"42","author":"J Rueda-Carrasco","year":"2023","unstructured":"Rueda-Carrasco J, Sokolova D, Lee S, Childs T, Jur\u010d\u00e1kov\u00e1 N, Crowley G, et al. Microglia-synapse engulfment via PtdSer-TREM2 ameliorates neuronal hyperactivity in Alzheimer\u2019s disease models. EMBO J. 2023;42: e113246.","journal-title":"EMBO J"},{"key":"504_CR336","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-022-02024-7","volume":"12","author":"H Targa Dias Anastacio","year":"2022","unstructured":"Targa Dias Anastacio H, Matosin N, Ooi L. Neuronal hyperexcitability in Alzheimer\u2019s disease: what are the drivers behind this aberrant phenotype? Transl Psychiatry. 2022;12:1\u201314.","journal-title":"Transl Psychiatry"},{"key":"504_CR337","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1021\/acschemneuro.0c00621","volume":"12","author":"J Zhao","year":"2021","unstructured":"Zhao J, Shi Q, Tian H, Li Y, Liu Y, Xu Z, et al. TDMQ20, a specific copper chelator, reduces memory impairments in Alzheimer\u2019s disease mouse models. ACS Chem Neurosci. 2021;12:140\u20139.","journal-title":"ACS Chem Neurosci"},{"key":"504_CR338","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1126\/science.aaz8899","volume":"368","author":"LM Guthrie","year":"2020","unstructured":"Guthrie LM, Soma S, Yuan S, Silva A, Zulkifli M, Snavely TC, et al. Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice. Science. 2020;368:620\u20135.","journal-title":"Science"},{"key":"504_CR339","doi-asserted-by":"crossref","unstructured":"Jenagaratnam L, McShane R. Clioquinol for the treatment of Alzheimer\u2019s Disease. Cochrane Database Syst Rev. 2006:(1):CD005380.","DOI":"10.1002\/14651858.CD005380.pub2"},{"key":"504_CR340","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1074\/jbc.M705957200","volume":"283","author":"PS Donnelly","year":"2008","unstructured":"Donnelly PS, Caragounis A, Du T, Laughton KM, Volitakis I, Cherny RA, et al. Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-\u03b2 peptide. J Biol Chem. 2008;283:4568\u201377.","journal-title":"J Biol Chem"},{"key":"504_CR341","doi-asserted-by":"publisher","first-page":"11829","DOI":"10.1039\/D2SC02593K","volume":"13","author":"M Okafor","year":"2022","unstructured":"Okafor M, Gonzalez P, Ronot P, Masoudi IE, Boos A, Ory S, et al. Development of Cu(II)-specific peptide shuttles capable of preventing Cu\u2013amyloid beta toxicity and importing bioavailable Cu into cells. Chem Sci. 2022;13:11829\u201340.","journal-title":"Chem Sci"},{"key":"504_CR342","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.132078","volume":"1251","author":"Y Li","year":"2022","unstructured":"Li Y, Nguyen M, Vendier L, Robert A, Liu Y, Meunier B. X-Ray diffraction structure of Cu(II) and Zn(II) complexes of 8-aminoquinoline derivatives (TDMQ), related to the activity of these chelators as potential drugs against Alzheimer\u2019s disease. J Mol Struct. 2022;1251: 132078.","journal-title":"J Mol Struct"},{"key":"504_CR343","first-page":"7825","volume":"24","author":"W Zhang","year":"2018","unstructured":"Zhang W, Liu Y, Hureau C, Robert A, Meunier B. N4 -tetradentate chelators efficiently regulate copper homeostasis and prevent ROS production induced by copper-amyloid-\u03b21-16. Chem Weinh Bergstr Ger. 2018;24:7825\u20139.","journal-title":"Chem Weinh Bergstr Ger"},{"key":"504_CR344","doi-asserted-by":"crossref","unstructured":"Okafor M, Schmitt D, Gasman S, Raibaut L, Hureau C, Faller P, et al. Next-generation Cu(II) selective peptide shuttles prevent Cu(A\u03b2)-induced toxicity and microglial activation in organotypic hippocampal slices. bioRxiv; 2024. p. 2024.09.04.611242.","DOI":"10.1101\/2024.09.04.611242"},{"issue":"2","key":"504_CR345","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1021\/acschemneuro.4c00796","volume":"16","author":"VE L\u00f3pez-Guerrero","year":"2025","unstructured":"L\u00f3pez-Guerrero VE, Posadas Y, S\u00e1nchez-L\u00f3pez C, Smart A, Miranda J, Singewald K, et al. A copper-binding peptide with therapeutic potential against Alzheimer\u2019s Disease: from the blood-brain barrier to metal competition. ACS Chem Neurosci. 2025;16(2):241\u201361.","journal-title":"ACS Chem Neurosci"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-025-00504-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-025-00504-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-025-00504-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T19:24:31Z","timestamp":1757445871000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-025-00504-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":345,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["504"],"URL":"https:\/\/doi.org\/10.1186\/s40035-025-00504-6","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest with the contents of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"42"}}